A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1584
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : Hib
Long Form : Haemophilus influenzae type b
No. Year Title Co-occurring Abbreviation
1977 Haemophilus influenzae type b disease. Incidence in a day-care center. ---
1978 Association between cross-reacting Escherichia coli K100 and disease caused by Haemophilus influenzae type b. ---
1978 Significance of noncapsular antigens in protection against experimental Haemophilus influenzae type b disease: cross-reactivity. ---
1979 Haemophilus influenzae type b antigenuria in children. ---
1980 Counterimmunoelectrophoresis in the diagnosis of Hemophilus influenzae pleural effusion. CIE
1980 Latex agglutination test for rapid detection of bacterial antigens in body fluids. CIE, CSF, LA, PN
1980 Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. ---
1981 A mucosal antibody response following systemic Haemophilus influenzae type B infection in children. ---
1981 Cefamandole failure in ampicillin-resistant Haemophilus influenzae b pneumonia. ---
10  1981 Fever in Haemophilus influenzae type B meningitis. ---
11  1981 Hemophilus influenzae type B buccal cellulitis. ---
12  1981 Mechanism of potentiation of experimental Haemophilus influenzae type B disease in infant rats by influenza A virus. ---
13  1981 Rifampin prophylaxis for contacts of Haemophilus influenzae type b disease. ---
14  1981 Ultrastructural histopathology of experimental Haemophilus influenzae type B. Meningitis in the infant rat. I. Leukocytes of the spinal leptomeninges. ---
15  1982 Cross-reactivity with Escherichia coli K100 in the human serum anticapsular antibody response to Haemophilus influenzae type B. CP
16  1982 Do pili play a role in pathogenicity of Haemophilus influenzae type B? EC, NP, RBC
17  1982 Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein. ---
18  1982 Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. ---
19  1982 Ultrastructural histopathology of experimental Haemophilus influenzae type B meningitis in the infant rat. II. Phagocytosis and lysis of microorganisms by leptomeningeal leukocytes. ---
20  1983 Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine on the incidence of epiglottitis and meningitis. ---
21  1983 Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model. DTP, PRP
22  1983 Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates. HCH, Pn6A, TT
23  1983 Mucosal antibody response to parenteral vaccination with Haemophilus influenzae type b capsule. PRP
24  1983 Viral enhancement of nasal colonization with Haemophilus influenzae type b in the infant rat. ---
25  1984 An evaluation of latex particle agglutination to detect antigenemia in children. LPA, Nm, SA, SP
26  1984 Development of respiratory mucosal tolerance during Haemophilus influenzae type B infection in infancy. NPS
27  1984 Fulminating haemophilus influenzae b meningitis. FM
28  1984 Immunogenic proteins in cell-free culture supernatants of Haemophilus influenzae type b. CFCS
29  1984 Quantitation of Haemophilus influenzae serotype b capsular polysaccharide antigen in body fluids by enzyme immunoassay. EIA, PRP
30  1984 Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates. CT, Pn6A, TT
31  1985 A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen. mAb
32  1985 Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. ---
33  1985 Cloning and surface expression in Escherichia coli of a structural gene encoding a surface protein of Haemophilus influenzae type b. mAbs
34  1985 Coprecipitation of lipopolysaccharide and the 39,000-molecular-weight major outer membrane protein of Haemophilus influenzae type b by lipopolysaccharide-directed monoclonal antibody. LPS, mAbs, RIP
35  1985 Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. ---
36  1985 Effect of piliation on interactions of Haemophilus influenzae type b with human polymorphonuclear leukocytes. CL, NHS, PMN
37  1985 Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts. ---
38  1985 Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b. ---
39  1985 Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. ---
40  1985 Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197. Ab, DTd, DTx
41  1985 Pharyngeal colonization with Haemophilus influenzae type b in children in a day care center without invasive disease. ---
42  1985 Preventing Haemophilus influenzae type b disease. ---
43  1985 Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. SDS
44  1985 Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. ---
45  1985 Serum factor-dependent resistance of Haemophilus influenzae type b to antibody to lipopolysaccharide. LPS, RES, SEN
46  1985 Supraglottitis and concurrent Hemophilus meningitis. ---
47  1985 Uridine monophosphate kinase 3: a genetic marker for susceptibility to Haemophilus influenzae type B disease. UMPK-3
48  1986 Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence. LPS, mAbs
49  1986 Cellular uptake and cell-associated activity of third generation cephalosporins. PMNs, SA
50  1986 Comparative analysis of Haemophilus influenzae type b and Escherichia coli J5 lipopolysaccharides. LPS
51  1986 Duration of pharyngeal carriage of Haemophilus influenzae type b in children hospitalized with systemic infections. IVAB
52  1986 Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae. ---
53  1986 Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b. CP, PMNLs
54  1986 Haemophilus influenzae b polysaccharide vaccine. Physician acceptance and use of a new vaccine. ---
55  1986 Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination. BE, LOS, OMP, PRP
56  1986 Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. ---
57  1986 Molecular epidemiology of Haemophilus influenzae type B: failure of rifampin prophylaxis in a day care center. ---
58  1986 Multiply-resistant Haemophilus influenzae type b causing systemic disease in children in Australia. ---
59  1986 Prevention of Haemophilus influenzae type b infections in day care: a public health perspective. ---
60  1986 Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. CL, OR
61  1986 Prospects for prevention of Haemophilus influenzae type b disease by immunization. OMPs, PS
62  1986 Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. IgM, Pn6A, TT
63  1986 Rifampin alone or with trimethoprim for contacts of children with Haemophilus influenzae type b infections. ---
64  1986 Sulbactam/ampicillin in the treatment of acute epiglottitis in children. ---
65  1986 Treatment of bacterial meningitis with ceftazidime. ---
66  1986 Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process. u.i
67  1986 Use of rifampin in Haemophilus influenzae type b infections. ---
68  1986 [Prospective evaluation of coagglutination and latex agglutination in the diagnosis of bacterial meningitis in childhood]. CoA, COA, CSF, LA, Nm, SP
69  1987 Cloning and expression in Escherichia coli of the gene encoding the heat-modifiable major outer membrane protein of Haemophilus influenzae type b. mAbs, SDS-PAGE
70  1987 Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b. LOS
71  1987 Dissociation of virulence and protection from infection by mutant analysis in Haemophilus influenzae type b. ---
72  1987 Effect of complement depletion on anticapsular-antibody-mediated immunity to experimental infection with Haemophilus influenzae type b. CoVF
73  1987 Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function. LPS
74  1987 Factors influencing immunogenicity and safety of two Haemophilus influenzae type b polysaccharide vaccines in children 18 and 24 months of age. ---
75  1987 Genetic factors in Haemophilus influenzae type b disease susceptibility and antibody acquisition. ---
76  1987 Haemophilus influenzae type b lipooligosaccharide: stability of expression and association with virulence. LOS
77  1987 Haemophilus influenzae type b strains of outer membrane subtypes 1 and 1c cause different types of invasive disease. OMP
78  1987 Haemophilus influenzae type b unsuspected bacteremia. ---
79  1987 Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine. ---
80  1987 Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. GVHD
81  1987 Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. BPIG
82  1987 Recurrent invasive Haemophilus influenzae type b disease in Alaskan Natives. ---
83  1987 Secondary cases of invasive disease caused by spread of Haemophilus influenzae type b. ---
84  1987 Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. PS
85  1987 Transmission of invasive Haemophilus influenzae type b disease in day care settings. OMP
86  1988 A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine. ---
87  1988 A nosocomial outbreak of ampicillin-resistant Haemophilus influenzae type b in a geriatric unit. ---
88  1988 Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. CPS
89  1988 Cloning of the gene encoding the major outer membrane protein of Haemophilus influenzae type b. ---
90  1988 Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine. KPMCP
91  1988 Functional activities of human antibody induced by the capsular polysaccharide or polysaccharide-conjugate vaccines against Haemophilus influenzae type b. PRP, PRP-D
92  1988 Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. BBB, BBBP, LPS
93  1988 Haemophilus influenzae type b anticapsular antibody responses to PRP-pertussis and PRP-D vaccines in Alaska native infants. ---
94  1988 Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. LOS
95  1988 Heterohybridomas secreting human monoclonal antibodies against Haemophilus influenzae type b. hMAb
96  1988 Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin. DT, HbOC, PRP-D
97  1988 IgG antibody response to polysaccharides in children with recurrent infections. ---
98  1988 Reimmunization of children immunized at 18 months of age with Haemophilus influenzae type b vaccine. PRP
99  1988 Role of cerebrospinal fluid pleocytosis and Haemophilus influenzae type b capsule on blood brain barrier permeability during experimental meningitis in the rat. BBBP, CSF
100  1988 Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels. ---
101  1988 [Assessment of a commonly available latex particle agglutination test in rapid, bacteriologic cerebrospinal fluid diagnosis]. CSF, Nm, SP
102  1988 [Systemic infections due to type b Haemophilus influenzae. A retrospective study of 114 cases]. ---
103  1989 Adherence kinetics of Haemophilus influenzae type b to eucaryotic cells. BEC
104  1989 Antigenic evidence for simultaneous expression of two different lipooligosaccharides by some strains of Haemophilus influenzae type b. LOS, mAbs
105  1989 Bacteriologic epidemiology of Hemophilus influenzae type b strains causing invasive infections in Finland. ---
106  1989 Excretion of Haemophilus influenzae type b polysaccharide antigen in urine of healthy nasopharyngeal carriers. ---
107  1989 Expression of the heat-modifiable major outer membrane protein of Haemophilus influenzae type b is unrelated to virulence. ---
108  1989 Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitis. LPS, OMV
109  1989 Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine. ---
110  1989 Induction of meningeal inflammation by outer membrane vesicles of Haemophilus influenzae type b. LOS, OMV
111  1989 Meningitis and epiglottitis: a new immunisation against haemophilus influenzae type b infections. HbO-C
112  1989 Meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. ---
113  1989 Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. CSF, TNF
114  1989 Primary structure of the porin protein of Haemophilus influenzae type b determined by nucleotide sequence analysis. ---
115  1989 Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Mnc, PNC
116  1989 Reactivity of Haemophilus influenzae type b anti-pili antibodies. ---
117  1989 Risk factors of invasive Haemophilus influenzae type b disease among children in Finland. ---
118  1989 Selective antibody deficiency to Haemophilus influenzae type B capsular polysaccharide vaccination in children with recurrent respiratory tract infection. HbOC
119  1989 Sources of low-molecular-weight host factors that phenotypically increase the resistance of Haemophilus influenzae type b to bacteriolysis: non-identity with a factor active in gonococci. ---
120  1989 Specific detection of Haemophilus influenzae type b lipooligosaccharide by a polymyxin B monoclonal antibody assay. CSF, LOS, mAb
121  1989 Structural and antigenic conservation of the P2 porin protein among strains of Haemophilus influenzae type b. mAbs
122  1989 Synthetic peptide representing a T-cell epitope of CRM197 substitutes as carrier molecule in a Haemophilus influenzae type B (Hib) conjugate vaccine. ---
123  1989 Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. DXM, i.c, LOS, TNF, WBC
124  1989 [Haemophilus influenzae type b vaccines]. ---
125  1989 [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age]. PRP
126  1990 Absent or minimal cerebrospinal fluid abnormalities in Haemophilus influenzae meningitis. ---
127  1990 Biochemical characterization and worldwide distribution of serologically distinct lipopolysaccharides of Haemophilus influenzae type b. LPS
128  1990 Carriage and antibiotic susceptibility of Haemophilus influenzae type b and non b in Danish day-care attendees. ---
129  1990 Characterization of a mutant of Haemophilus influenzae type b lacking the P2 major outer membrane protein. ---
130  1990 Cloning and expression in Escherichia coli of a Haemophilus influenzae type b lipooligosaccharide synthesis gene(s) that encodes a 2-keto-3-deoxyoctulosonic acid epitope. KDO, LOS, LPS, mAb
131  1990 Cloning, expression, and sequence analysis of the Haemophilus influenzae type b strain M43p+ pilin gene. ---
132  1990 Conserved and nonconserved epitopes among Haemophilus influenzae type b pili. ---
133  1990 Decline in Haemophilus influenzae type b meningitis--Seattle-King County, Washington, 1984-1989. PRP
134  1990 Effect of intravenous gammaglobulin therapy in IgG2 deficient and IgG2 sufficient children with recurrent infections and poor response to immunization with Hemophilus influenzae type b capsular polysaccharide antigen. IVIG
135  1990 Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b. LOS
136  1990 Effectiveness of Haemophilus influenzae type b vaccines. PRP-D
137  1990 Expression in Escherichia coli of a high-molecular-weight protective surface antigen found in nontypeable and type b Haemophilus influenzae. ---
138  1990 Haemophilus influenzae B meningitis in a patient with a ventriculoperitoneal shunt and meningomyelocele. CSF, VP
139  1990 Haemophilus influenzae type b infections in Victoria, Australia, 1985 to 1987. ---
140  1990 Induction of an immune response to the porin of Haemophilus influenzae type b by monoclonal anti-idiotypic antibodies. mAb, OMP
141  1990 Kappa and lambda light chain composition of antibody to the capsular polysaccharide of Haemophilus influenzae type b. ---
142  1990 Outbreak of Haemophilus influenzae type b meningitis in a day care center. Hi
143  1990 Pilus- and non-pilus-mediated interactions of Haemophilus influenzae type b with human erythrocytes and human nasopharyngeal mucosa. NP
144  1990 Quantitation of antibody-secreting cells in the blood after vaccination with Haemophilus influenzae type b conjugate vaccine. AbSC
145  1990 Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide. ---
146  1990 Risk of Haemophilus influenzae type b disease in children with cancer and response of immunocompromised leukemic children to a conjugate vaccine. ---
147  1990 Serum immunoglobulin levels and natural antibodies to Haemophilus influenzae in hemodialysis patients: evidence for IgG subclass imbalances. PS
148  1990 Specific detection of Haemophilus influenzae type b lipooligosaccharide by immunoassay. LOS, mAb
149  1990 Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia. Ab, AbN, TT
150  1990 Subnormal serum concentrations of IgG2 in children with frequent infections associated with varied patterns of immunologic dysfunction. ---
151  1990 The complete primary structure of pilin from Haemophilus influenzae type b strain Eagan. ---
152  1990 Three-dose vaccination of infants under 8 months of age with a conjugate Haemophilus influenzae type B vaccine. ---
153  1991 An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera. ELISA, GMT, OMPC, PRP
154  1991 Analysis of Haemophilus influenzae type b lipooligosaccharide-synthesis genes that assemble or expose a 2-keto-3-deoxyoctulosonic acid epitope. LOS, LPS
155  1991 Antigenuria after immunization with Haemophilus influenzae oligosaccharide CRM197 conjugate (HbOC) vaccine. ---
156  1991 Biological activity of Hib conjugates. ---
157  1991 Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide--Neisseria meningitidis outer membrane protein. ---
158  1991 Comparison and analysis of the nucleotide sequences of pilin genes from Haemophilus influenzae type b strains Eagan and M43. ---
159  1991 Contribution of a 28-kilodalton membrane protein to the virulence of Haemophilus influenzae. ---
160  1991 Detection of experimental Haemophilus influenzae type b bacteremia and endotoxemia by means of an immunolimulus assay. IML, LAL
161  1991 Effects of age, breast feeding, and household structure on Haemophilus influenzae type b disease risk and antibody acquisition in Alaskan Eskimos. ---
162  1991 Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group. PRP
163  1991 Epidemiology of Haemophilus influenzae type b disease in Australia and New Zealand. ---
164  1991 Epidemiology of invasive Haemophilus influenzae type b infections in Geneva, Switzerland, 1976 to 1989. ---
165  1991 Experience in Finland with Haemophilus influenzae type b vaccines. ---
166  1991 Haemophilus influenzae type b bacteremia in older children. ---
167  1991 Host metabolites that phenotypically increase the resistance of Haemophilus influenzae type b to clearance mechanisms. ---
168  1991 Immunogenicity of four Haemophilus influenzae type b conjugate vaccines in 17- to 19-month-old children. OMP, PRP-D, PRP-T
169  1991 Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys. PRP
170  1991 In vitro cytotoxicity of Haemophilus influenzae lipopolysaccharides for bovine aortal endothelial cells. BAOEC, LDH, LPS
171  1991 In vitro induction of IgG1 and IgG2 secretion by B cells of children who developed invasive haemophilus disease despite vaccination. ---
172  1991 In vivo and in vitro expression of Haemophilus influenzae type b lipooligosaccharide epitopes. CSF, LOS, mAbs
173  1991 Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-alpha, and interleukin-1 beta. IL-1 beta, LOS, TNF-alpha
174  1991 Invasive Haemophilus influenzae type b disease in Sydney children 1985-1987: a population-based study. SSD
175  1991 Molecular cloning of a gene involved in lipooligosaccharide biosynthesis and virulence expression by Haemophilus influenzae type B. LOS, mAb
176  1991 Molecular cloning, partial purification, and characterization of a haemin-binding lipoprotein from Haemophilus influenzae type b. ---
177  1991 Molecular epidemiology of Haemophilus influenzae within families in Santiago, Chile. OMP
178  1991 Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide. PRP
179  1991 New protection against Haemophilus influenzae type b infections in infants and young children. ---
180  1991 Pathogenic events during infection of the human nasopharynx with Neisseria meningitidis and Haemophilus influenzae. ---
181  1991 Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. CPS, TT
182  1991 Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. ---
183  1991 Relationship between intracellular survival in macrophages and virulence of Haemophilus influenzae type b. ---
184  1991 Susceptibility to invasive Haemophilus influenzae type b disease and the immunoglobulin G2m(n) allotype. ---
185  1991 Treatment of meningitis and other infections due to ampicillin-resistant Haemophilus influenzae type b in children. CNS
186  1991 [Acute epiglottitis]. ---
187  1991 [Costs and benefits of vaccination against Haemophilus influenzae type b]. ---
188  1991 [Evaluation of the vaccination of 3-month-old infants with Haemophilus influenzae type B (Hi b) capsular polysaccharide conjugated to tetanus protein (PRT-T) Pediatric Group of the Lyon Region]. PRP-T
189  1992 A prospective, population-based study of Haemophilus influenzae type b meningitis in The Gambia and the possible consequences. ---
190  1992 A two-year prospective, nationwide study to determine the epidemiology and impact of invasive childhood Haemophilus influenzae type b infection in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. ---
191  1992 Antibody response to a Haemophilus influenzae type b polysaccharide tetanus toxoid conjugate vaccine in splenectomized children and adolescents. ---
192  1992 Antigenic sites on porin of Haemophilus influenzae type b: mapping with synthetic peptides and evaluation of structure predictions. mAbs
193  1992 Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. PRP
194  1992 C4B deficiency is not associated with meningitis or bacteremia with encapsulated bacteria. ---
195  1992 Changes in the distribution of Haemophilus influenzae type b clones associated with widespread infant vaccination in Finland. BT, LPS, OMP
196  1992 Characterization of the human IgG antibody VL repertoire to Haemophilus influenzae type b polysaccharide. ---
197  1992 Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections. ---
198  1992 Childhood bacterial meningitis in Al-Baha province, Saudi Arabia. ---
199  1992 Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. IgG2, TT
200  1992 Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies. IgG, OMP, PRP
201  1992 Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. ---
202  1992 Duration of rifampin chemoprophylaxis for contacts of patients infected with Haemophilus influenzae type B. ---
203  1992 Effect of pertussis toxin on susceptibility of infant rats to Haemophilus influenzae type b. ---
204  1992 Effect of pili-specific antibodies on the adherence of Haemophilus influenzae type b to human buccal cells. ---
205  1992 Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. ---
206  1992 Efficacy of Haemophilus influenzae type b vaccines in Massachusetts children 18 to 59 months of age. PE
207  1992 Epidemiology of acute lower respiratory tract infections, especially those due to Haemophilus influenzae type b, in The Gambia, west Africa. ALRI
208  1992 Epidemiology of invasive Haemophilus influenzae type b disease. ---
209  1992 Epitope analysis of an immunodominant domain on the P1 protein of Haemophilus influenzae type b using synthetic peptides and anti-idiotypic antibodies. anti-Id, mAbs
210  1992 Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. BPIG
211  1992 G2m(23) immunoglobulin allotype and immunity to Haemophilus influenzae type b. ---
212  1992 Generation of lipooligosaccharide mutants of Haemophilus influenzae type b. LPS, mAbs
213  1992 Growth of Haemophilus influenzae type b in continuous culture: effect of dilution rate on outer-membrane protein and lipopolysaccharide expression. ---
214  1992 Haemophilus influenzae lipopolysaccharide disrupts confluent monolayers of bovine brain endothelial cells via a serum-dependent cytotoxic pathway. BBB, LPS
215  1992 Haemophilus influenzae type B conjugate vaccines. ---
216  1992 Haemophilus influenzae type b vaccines. ---
217  1992 IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants. PRP-OMPC
218  1992 Immunity to Haemophilus influenzae type b on sample population from central Italy. RABA
219  1992 Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. Hib-CPS
220  1992 Immunoglobulin variable region gene expression in response to Haemophilus influenzae type b polysaccharide. ---
221  1992 Monoclonal antibodies specific to porin of Haemophilus influenzae type b: localization of their cognate epitopes and tests of their biological activities. ---
222  1992 National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children. NACI
223  1992 New considerations for Haemophilus influenzae type b vaccination. AAP
224  1992 Outcome of children with occult bacteremia caused by Haemophilus influenzae type b. ---
225  1992 Outer membrane protein subtypes of Haemophilus influenzae type b isolates causing invasive disease in Victoria, Australia, from 1988 to 1990. ---
226  1992 Prevention of Haemophilus influenzae type b infections in Apache and Navajo children. ---
227  1992 Primary prevention of haemophilus influenzae type b. ---
228  1992 Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. EIAs, IUIS, PLL, PRP
229  1992 Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. PRP-D
230  1992 Recombinant porin of Haemophilus influenzae type b. ---
231  1992 Relation between enzyme-linked immunosorbent assay and radioimmunoassay for detection of antibodies to the capsular polysaccharide of Haemophilus influenzae type b. ELISA
232  1992 Response to Haemophilus influenzae type B conjugate vaccine in children undergoing splenectomy. ---
233  1992 Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. ---
234  1992 Socioeconomic risk factors for invasive Haemophilus influenzae type b disease. ---
235  1992 The biology of Haemophilus influenzae type b vaccination failure. ---
236  1992 The genetics of encapsulation in Haemophilus influenzae. ---
237  1992 The introduction of Haemophilus influenzae B (Hib) vaccine. ---
238  1992 The role of complement in the host's defense against Haemophilus influenzae. ---
239  1992 [Chemoprophylaxis in indirectly related cases of Haemophilus influenzae meningitis]. ---
240  1992 [Environmental chemoprevention of Haemophilus influenzae type B meningitis. Consequences of 2 indirectly related case pairs]. ---
241  1993 Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. PS
242  1993 Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. PS, sIgA
243  1993 Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. TNF
244  1993 Antibodies to Haemophilus influenzae type b outer membrane proteins in children with epiglottitis or meningitis and in healthy controls. OMP
245  1993 Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine. ---
246  1993 Antigenuria in healthy Papua New Guinean children with nasal Haemophilus influenzae type b carriage. PS
247  1993 Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? ---
248  1993 Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. ---
249  1993 Childhood epiglottitis in recent years. ---
250  1993 Clinical and serologic responses of Saudi children to Hemophilus influenzae type B capsular polysaccharide diphtheria toxoid conjugate vaccine. PRP-D
251  1993 Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. PRP-D, PRP-OMP, PRP-T
252  1993 Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide. HbOC, IgG, PRP
253  1993 Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries. ---
254  1993 Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel. ---
255  1993 Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile. DTP
256  1993 Day care attendance and other risk factors for invasive Haemophilus influenzae type b disease. CI, ORs
257  1993 Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. NBMRS
258  1993 Defective antibody response to Hemophilus influenzae type b immunization in children receiving peritoneal dialysis. CPD
259  1993 Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus influenzae type b in Sudanese and Swedish children. ---
260  1993 Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. DTP
261  1993 Effect of respiratory syncytial virus infection on binding of Neisseria meningitidis and Haemophilus influenzae type b to a human epithelial cell line (HEp-2). RSV
262  1993 Effect of specific bacteria on lymphocyte proliferation in diseased and nondiseased tonsils. DB, LA, SI, TTL
263  1993 Efficacy of passive immunotherapy in experimental postsplenectomy sepsis due to Haemophilus influenzae type B. IVIG
264  1993 Epidemiology of Haemophilus influenzae type b (Hib) meningitis in South Australia. ---
265  1993 Epidemiology of invasive Haemophilus influenzae type b (Hib) disease in Israel. ---
266  1993 Epidemiology of invasive Haemophilus influenzae type b disease in Scandinavia. ---
267  1993 Genomic DNA fingerprints and phenotypic characteristics of serotype B Haemophilus influenzae isolates from Italy. ---
268  1993 Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine. HbOC
269  1993 Haemophilus influenzae type B impairment of pial vessel autoregulation in rats. ---
270  1993 Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children. ---
271  1993 Haemophilus influenzae type b. Conjugate vaccines for use in infants and children. ---
272  1993 Immunological properties of recombinant porin of Haemophilus influenzae type b expressed in Bacillus subtilis. ---
273  1993 Impact of Haemophilus influenzae type b vaccines on the epidemiology of bacterial meningitis. ---
274  1993 Interaction of the capsular polysaccharide of Haemophilus influenzae type B with C1q. LOS, OMP, PRP
275  1993 Invasive Haemophilus influenzae type b disease. ---
276  1993 Need for prevention of invasive Haemophilus influenzae type b infections in Geneva, Switzerland. ---
277  1993 Outer membrane protein binding sites of complement component 3 during opsonization of Haemophilus influenzae. mAbs, OMPs
278  1993 Paradoxical effect of pilus expression on binding of antibodies by Haemophilus influenzae. ---
279  1993 Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. hFc gamma, PMN
280  1993 Pharmacoeconomics of immunisation: a review. ---
281  1993 Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease. ---
282  1993 Prevention of Haemophilus influenzae type b disease. BPIG, PRP
283  1993 Proportion of protein A bindable molecules in human IgM and IgA antibodies to seven antigens. ---
284  1993 Rational use of Haemophilus influenzae type b vaccine. DPT, PRP
285  1993 Reactivity of antibodies against conserved regions of pilins of Haemophilus influenzae type b. ---
286  1993 Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine formulation in healthy adults. anti-PRP, HBV
287  1993 The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. GMT, PCP, TT
288  1993 The epidemiology of Haemophilus influenzae invasive disease in Scotland prior to immunisation. ---
289  1993 The human VH3b gene subfamily is highly polymorphic. Ab
290  1993 The outcome of childhood Haemophilus influenzae meningitis. A population based study. CI, OR
291  1993 The retreat of Hemophilus influenzae type B invasive disease: analysis of an immunization program and implications for OTO-HNS. ---
292  1993 Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. OP
293  1993 World-wide strategies for immunization against invasive Haemophilus influenzae type b disease. ---
294  1993 [Haemophilus influenzae type B (Hib) meningitis in a 14-month-old child despite two vaccinations with Hib conjugate vaccine (PRP-D)]. ---
295  1993 [The PRP-D vaccination of Danish children. A study of immunogenicity of a Haemophilus influenzae type b vaccine coadministered with Di-Te-Pol to Danish children]. ---
296  1994 Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. ---
297  1994 An audit of Haemophilus influenzae B (HIB) immunization training sessions in Mid Glamorgan. ---
298  1994 An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease. QALY
299  1994 An increase in Haemophilus influenzae type B vaccination among preschool-aged children in inner-city Los Angeles, 1990 through 1992. CI
300  1994 Bacterial meningitis in the pediatric population: paradigm shifts and ramifications for otolaryngology-head and neck surgery. ---
301  1994 Cerebrovascular responsiveness to CO2 in Haemophilus influenzae type b meningitis in rabbits. rCBF
302  1994 Changing patterns in pediatric supraglottitis: a multi-institutional review, 1980 to 1992. ---
303  1994 Characterization of a monoclonal antibody to the capsule of Haemophilus influenzae type b, generated by in vitro immunization. PRP
304  1994 Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy. CL, PRP-D
305  1994 Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity. ---
306  1994 Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency. ---
307  1994 Cost of treatment and prevention of Haemophilus influenzae type b disease. An international perspective. ---
308  1994 Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden. ---
309  1994 Decline of Haemophilus influenzae type b disease in a region of high risk: impact of passive and active immunization. BPIG, YKD
310  1994 Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines. PS
311  1994 Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. ---
312  1994 Evaluation of health, sanitation, and nutrition in Forces Command Child Development Centers. ---
313  1994 Haemophilus influenzae type B epiglottitis after immunization with HbOC conjugate vaccine. ---
314  1994 Haemophilus influenzae type B invasive disease in urban and rural children: immunization patterns and prevalence of disease. ---
315  1994 Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity. AbSC, DT, IgG1, TT
316  1994 Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. IL-6, LPS, TNF-alpha
317  1994 Identification of a gene essential for piliation in Haemophilus influenzae type b with homology to the pilus assembly platform genes of gram-negative bacteria. ---
318  1994 Identification of a new locus involved in expression of Haemophilus influenzae type b lipooligosaccharide. LOS, mAb, ORFs
319  1994 Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of Haemophilus vaccine. HIV
320  1994 Impact of immunization against Haemophilus influenzae type b (HIB) on the incidence of HIB meningitis treated at Arkansas Children's Hospital. ACH
321  1994 Induction of a protective human polysaccharide-specific antibody response in hu-PBL SCID mice by idiotypic vaccination. Id, PS
322  1994 Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests. ---
323  1994 National Advisory Committee on Immunization (NACI). Supplementary statement on newly licensed Haemophilus influenzae type B (HIB) conjugate vaccines in combination with other vaccines recommended for infants. NACI
324  1994 National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. ---
325  1994 Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. TT
326  1994 Polysaccharide conjugate vaccine responses in bone marrow transplant patients. PS
327  1994 Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children. CI
328  1994 Progress in the prevention of hearing loss in infants. ---
329  1994 Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1993. Hi
330  1994 Protection provided by Haemophilus influenzae type b conjugate vaccines in Los Angeles County: a case-control study. CI
331  1994 Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection. PS
332  1994 Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative. CII, CRS
333  1994 Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Fc gamma R, NA1, NMen, PMN, STAW
334  1994 Sequelae of Haemophilus influenzae type b meningitis in aboriginal and non-aboriginal children under 5 years of age. ---
335  1994 Update: childhood vaccine-preventable diseases--United States, 1994. CII, CRS
336  1994 Use of vaccines and antibiotic prophylaxis in contacts and cases of Haemophilus influenzae type b (Hib) disease. ---
337  1994 Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. mAb
338  1994 Voltage gating of porins from Haemophilus influenzae type b. ---
339  1994 [Effect of conjugated PRP vaccines on the incidence of invasive diseases caused by Haemophilus influenzae Type B in childhood]. ---
340  1994 [Haemophilus influenzae meningitis 1983 to 1992--epidemiology and sequelae of the disease]. ---
341  1994 [Haemophilus influenzae type b infections and its prevention by vaccines]. ---
342  1994 [Vaccination of splenectomized children. Antibody response to Haemophilus influenzae type b conjugate vaccine]. ---
343  1995 A case-control study examining risk factors for invasive Haemophilus influenzae type b disease in Victoria, Australia 1988-90. ---
344  1995 A gene cluster involved in the utilization of both free heme and heme:hemopexin by Haemophilus influenzae type b. ---
345  1995 A population-based survey of immunisation coverage in two-year-old children. ---
346  1995 A rapid and sensitive chemiluminescence assay for evaluation of functional opsonic activity of Haemophilus influenzae type b-specific antibodies. CL, Hib-PRP
347  1995 Analysis of the results of routine lumbar puncture after a first febrile convulsion in Hofuf, Al-Hassa, Saudi Arabia. CFC, CSF, LP, SFC
348  1995 Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. PS
349  1995 Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine. LBW
350  1995 Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection. ---
351  1995 Antibody responses to Haemophilus influenzae type b and Streptococcus pneumoniae vaccines in children with human immunodeficiency virus infection. ---
352  1995 Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease. ---
353  1995 Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b. ELISA, PRP, PRP-OMP, PRP-T
354  1995 Case-cohort analysis of case-coverage studies of vaccine effectiveness. ---
355  1995 Characterization of the antibody response to a Haemophilus influenzae type b conjugate vaccine in children with recurrent lower respiratory tract infection. RLRI
356  1995 Childhood bacterial meningitis in Southwestern Greece: a population-based study. ---
357  1995 Clinical manifestations and outcome of Haemophilus influenzae type b disease. ---
358  1995 Complement-mediated bactericidal activity of human antibodies to poly alpha 2-->8 N-acetylneuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. mAbs, MenB
359  1995 Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine program in Florida. ---
360  1995 Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines. PRP
361  1995 Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) via the experience of the Children's Hospital La Fe, Valencia, Spain. ---
362  1995 Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children. ---
363  1995 Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection. IL, IL-1ra, LOS, sTNFR
364  1995 Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. DT, HbOC, PRP-T
365  1995 Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines. PRP-OMP, PRP-T
366  1995 Epiglottitis and Haemophilus influenzae immunization: the Pittsburgh experience--a five-year review. ---
367  1995 Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide. Abs, PS
368  1995 Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type B polysaccharide-protein conjugates. PS
369  1995 Haemophilus influenzae: then and now. ---
370  1995 Hematogenous bacterial meningitis in an intercellular adhesion molecule-1-deficient infant mouse model. CSF, ICAM-1
371  1995 Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster therapy. ALL, BFM
372  1995 Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. ---
373  1995 Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia. B-CLL
374  1995 Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. OMP, PRP
375  1995 Invasive Haemophilus influenzae disease: epidemiology and clinical spectrum before large-scale H. influenzae type b vaccination. Hi
376  1995 Management of asplenic patients in South Buckinghamshire: an audit of local practice. ---
377  1995 Monitoring the uptake of Hib vaccine in Forth Valley. ---
378  1995 Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. PS
379  1995 Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up. ---
380  1995 Production of Haemophilus influenzae type-b porin in Escherichia coli and its folding into the trimeric form. re-P2
381  1995 Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1993-1994. CII, NBMBRS, NNDSS
382  1995 Qualitative and quantitative immunoglobulin production by specific bacteria in chronic tonsillar disease. DB, IgA, IgG, IgM, ITH, LA, RT, SP, TTL
383  1995 Recent advances in the large scale fermentation of Neisseria meningitidis group B for the production of an outer membrane protein complex. cGMP, OMPC, PN
384  1995 Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine. HIV
385  1995 Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4. ---
386  1995 Supplementary statement on newly licensed Haemophilus influenzae type B (Hib) conjugate vaccines in combination with other vaccines recommended for infants. ---
387  1995 The costs and benefits of a vaccination programme for Haemophilus influenzae type B disease. ---
388  1995 The elucidation of novel capsular genotypes of Haemophilus influenzae type b with the polymerase chain reaction. cap, PCR
389  1995 The epidemiology of Haemophilus influenzae type b disease in the Republic of Ireland. ---
390  1995 The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. ---
391  1995 The impact of vaccination against invasive Haemophilus influenzae type b disease in the Sydney region. ---
392  1995 The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants. Abs, PS
393  1995 Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. ---
394  1995 Type b Haemophilus influenzae endocarditis in children: case report and review of the literature. ---
395  1995 [Absence of meningitis caused by Haemophilus influenzae type b in The Netherlands following twofold vaccination]. ---
396  1995 [Epidemiology of invasive infections with Haemophilus influenzae type b in the world and in Italy]. ---
397  1995 [Pediatric surveillance of invasive infections caused by Haemophilus influenzae type b in children in the period following introduction of vaccination]. ---
398  1995 [Vaccine against Haemophilus influenzae type b--antibody response and adverse effects]. DTP
399  1996 A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. PncPS
400  1996 Analysis of Haemophilus influenzae type B conjugate and diphtheria-tetanus-pertussis combination vaccines. Pa
401  1996 Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes. IL-1ra, LPS, PMA, TNF-alpha
402  1996 Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication. mAb, PS
403  1996 Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization. PRP
404  1996 Antibody responses to Haemophilus influenzae type b conjugate vaccine in sickle cell disease. CI, HbSC, HbSS
405  1996 Characterization of two transposon mutants from Haemophilus influenzae type b with altered lipooligosaccharide biosynthesis. LOS
406  1996 Cloning and expression of the Haemophilus influenzae transferrin receptor genes. NTHi, PCR
407  1996 Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. DTP, IPV
408  1996 Conjugate vaccines and the carriage of Haemophilus influenzae type b. ---
409  1996 Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France. ---
410  1996 Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines. DT, DTaP, FHA, PRP, PTxd, TT, US
411  1996 Dexamethasone in bacterial meningitis: to use or not to use? IL-1, TNF
412  1996 Differing antibody responses to Haemophilus influenzae type b after meningitis or epiglottitis. ---
413  1996 Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. ---
414  1996 Experimental infection by Haemophilus influenzae type b in inbred mice. VEF
415  1996 Expression of Haemophilus influenzae type b idiotype 1 on naturally acquired antibodies. CP, Id-1, IEF
416  1996 Haemophilus influenzae type b (Hib) vaccination and uptake predictors in Northern Ireland. ---
417  1996 Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation. ABMT, BM
418  1996 Haemophilus influenzae type b immunization in infants on peritoneal dialysis. Pediatric Peritoneal Dialysis Study Consortium. CPD
419  1996 Hemophilus influenzae type b meningitis: pediatric overview. CFS
420  1996 Immunity to Haemophilus influenzae type b polysaccharide capsule after vaccination with the complete series of oligosaccharide CRM197 conjugate vaccine in infants with human immunodeficiency virus infection. ---
421  1996 Immunoglobulin allotypes and genetic susceptibility to invasive Haemophilus influenzae type b and Staphylococcus aureus infections in South African children. S. aureus
422  1996 Impact of immunization on Haemophilus influenzae type b disease. ---
423  1996 Impact of Uruguay's introduction of the Haemophilus influenzae type b (Hib) vaccine. ---
424  1996 Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. PRP-T
425  1996 Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. BMT
426  1996 Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. ---
427  1996 Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model. PS
428  1996 Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines. FPLC, PRP
429  1996 Overcoming barriers and reaping the benefits of surveillance for infectious diseases: the New Mexico perspective. AIDS
430  1996 Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. DTP, GMC, PS
431  1996 Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection. ---
432  1996 Priming with diphtheria-tetanus-pertussis vaccine enhances the response to the Haemophilus influenzae type b tetanus conjugate vaccine in infancy. DTP, PS
433  1996 Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995. CII, Hi, NBMBRS, NNDSS
434  1996 Purification and refolding of recombinant Haemophilus influenzae type b porin produced in Bacillus subtilis. ---
435  1996 Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. dTpa, IPV
436  1996 Reasons for instability of bacterial vaccines. DTP
437  1996 Recent trends in pediatric Haemophilus influenzae type B infections in Canada. Immunization Monitoring Program, Active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease Control. IMPACT
438  1996 Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine. GMTs, HIV, Pa
439  1996 Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study Group. ---
440  1996 Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination. DT
441  1996 Study of booster doses of two Haemophilus influenzae type b conjugate vaccines including their interchangeability. ---
442  1996 The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines. ---
443  1996 The contribution of the case-control approach to vaccine evaluation: Pneumococcal and Haemophilus influenzae type B PRP vaccines. ---
444  1996 The effect of mutations in genes required for lipopolysaccharide synthesis on Haemophilus influenzae type b colonization of human nasopharyngeal tissue. CFU, galEK, LPS
445  1996 The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants. GMC
446  1996 Unique case presentations of acute epiglottic swelling and a protocol for acute airway compromise. ---
447  1996 [Haemophilus influenzae meningitis following vaccination. Consequence or coincidence?]. ---
448  1996 [Immunization against Haemophilus influenzae type b in Iceland. Results after six years use of PRP-D (ProHIBiT(R).]. ---
449  1996 [Pneumonia due to Haemophilus influenzae type b in children: presentation of 24 cases]. ---
450  1996 [Serum antibodies against Haemophilus influenzae in children from the province of Valladolid (Spain)]. ---
451  1997 A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. ---
452  1997 A resolved pneumococcal infection protects against nontypeable Haemophilus influenzae: an evaluation of different routes of whole cell immunization in protection against experimental acute otitis media. AOM, NTHi
453  1997 A strategy for rational design of fully synthetic glycopeptide conjugate vaccines. OMPs, sPRP
454  1997 Administration of combined diphtheria and tetanus toxoids and pertussis vaccine, hepatitis B vaccine, and Haemophilus influenzae type b (Hib) vaccine to infants and response to a booster dose of Hib conjugate vaccine. DTaP, PRN
455  1997 Anti-CD11b monoclonal antibody in an infant rat model of Haemophilus influenzae type b sepsis and meningitis. i.p, PBS
456  1997 Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status. ---
457  1997 Antibody response to Haemophilus influenzae type b vaccine in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. HIV, PRP
458  1997 Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT). PBSCT, TT
459  1997 Childhood meningitis at King Fahad Hospital, Hofuf, Saudi Arabia. ---
460  1997 Cytokine mRNA profiles during the course of experimental Haemophilus influenzae bacterial meningitis. CSF, p.i
461  1997 Decline of pediatric admissions with Haemophilus influenzae type b in New York State, 1982 through 1993: relation to immunizations. ---
462  1997 Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta IL-10 by human leucocytes. GNB, GPB, IL-1 beta, IL-10, LPS, LSF, PTX, TNF-alpha
463  1997 Epidemiology and prevention of pneumococcal disease. ---
464  1997 Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate Hib-DTPa-HBV combined vaccine. ---
465  1997 FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine. ACIP, FDA, HBV
466  1997 Fragmentation of scheduled visits and missed doses among infants receiving multiple injected vaccines. DTP
467  1997 Haemophilus influenzae and Streptococcus pneumoniae induce different intracerebral mRNA cytokine patterns during the course of experimental bacterial meningitis. IFN-gamma, p.i, TGF-beta, TNF-alpha
468  1997 Haemophilus influenzae type b disease and vaccination in Latin America and the Caribbean. ---
469  1997 Haemophilus influenzae type b vaccine in India: need and timing, immunogenecity and tolerance. ---
470  1997 Haemophilus influenzae type b-specific antibody in infants after maternal immunization. ---
471  1997 Identification of two minor subunits in the pilus of Haemophilus influenzae. ---
472  1997 Immunization practices in children with renal disease: a report of the North American Pediatric Renal Transplant Cooperative Study. HepB, MMR, OPV
473  1997 Immunogenicity of Haemophilus influenzae b conjugate vaccine (HibTITER) and safety of HibTITER and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER in infants two months of age: a preliminary report. DTP
474  1997 Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine. IPV, OPV
475  1997 Incidence of invasive Haemophilus influenzae type b disease in Italian children. ---
476  1997 Invasive Haemophilus influenzae type b (Hib) infection in an adult patient with a selective deficiency of antibody to the Hib capsular polysaccharide. ---
477  1997 Invasive Haemophilus influenzae type b disease in elderly nursing home residents: two related cases. ---
478  1997 MF59 adjuvant enhances antibody responses of infant baboons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosaccharide-CRM197 conjugate vaccine. PBS
479  1997 Nasopharyngeal colonization with Haemophilus influenzae type b among infants and children in Japan. ---
480  1997 Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease. NTHi, rD15
481  1997 Phase I study of the immunogenicity and safety of conjugated Hemophilus influenzae type b vaccines in the elderly. ---
482  1997 Porins of Haemophilus influenzae type b mutated in loop 3 and in loop 4. ---
483  1997 Pyrolysis mass spectrometry in epidemiological and population genetic studies of Haemophilus influenzae. MLEE, ncHi, PMS
484  1997 Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. DTP
485  1997 Recommended childhood immunization schedule--United States, 1997. AAFP, AAP, ACIP, DTaP, IPV, OPV, VAPP
486  1997 Safety and immunogenicity of a conjugated Haemophilus influenzae type B polysaccharide-Neisseria meningitidis outer membrane protein vaccine. PRP
487  1997 Spectrum of Haemophilus influenzae type b disease in children at a university hospital in Riyadh, Saudi Arabia. ---
488  1997 Status report on the Childhood Immunization Initiative: reported cases of selected vaccine-preventable diseases--United States, 1996. CII
489  1997 The baboon as a nonhuman primate model for assessing the effects of maternal immunization with Haemophilus influenzae type b polysaccharide vaccines. IgG, PRP
490  1997 The decline of Haemophilus influenzae type b disease in Australia. ---
491  1997 The effect of interleukin-10 on meningeal inflammation in experimental bacterial meningitis. CSF, IL-10, LOS, TNF-alpha
492  1997 The tympanic membrane and middle ear mucosa during non-typeable Haemophilus influenzae and Haemophilus influenzae type b acute otitis media: a study in the rat. AOM, NTHi, TM
493  1997 Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants. ---
494  1997 Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. HbOC, PRP-T
495  1997 [Acute epiglottitis caused by Haemophilus influenzae type b in children: presentation of 21 cases]. ---
496  1998 A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group. ---
497  1998 A polymerase chain reaction for the diagnosis of Haemophilus influenzae type b disease in children and its evaluation during a vaccine trial. ---
498  1998 A population-based survey of Haemophilus influenzae type b nasopharyngeal carriage prevalence in Lombok Island, Indonesia. ---
499  1998 Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996-97. BM, CFR, QECH
500  1998 Aetiology of acute epiglottitis in adults. PCR
501  1998 An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia. ---
502  1998 Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. ---
503  1998 Antigen-specific antibody responses in lupus patients following immunization. SLE, TT
504  1998 Antigenuria in Gambian infants following immunization with a Haemophilus influenzae type b polyribosylribitol phosphate-tetanus toxoid protein conjugate (PRP-T) vaccine. PRP-T
505  1998 Blood cultures in the evaluation of children with cellulitis. BNR
506  1998 CD1 presents antigens from a gram-negative bacterium, Haemophilus influenzae type B. DN, LAM
507  1998 Characterization of immune response as an indicator of Haemophilus influenzae type b vaccine efficacy. ---
508  1998 Childhood bacterial meningitis in Japan. ---
509  1998 Decreased frequency of rearrangement due to the synergistic effect of nucleotide changes in the heptamer and nonamer of the recombination signal sequence of the V kappa gene A2b, which is associated with increased susceptibility of Navajos to Haemophilus influenzae type b disease. RSS
510  1998 Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden. ---
511  1998 Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. DTP
512  1998 Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. ---
513  1998 Epidemiology of invasive Haemophilus influenzae type b infections among children in Greece before the introduction of immunization. ---
514  1998 Epidemiology of systemic Haemophilus influenzae disease in Korean children. ---
515  1998 Geographic differences in bacterial meningitis: less may be as interesting as more. ---
516  1998 Haemophilus influenzae invasive disease among children aged <5 years--California, 1990-1996. ACIP, Hi
517  1998 Haemophilus influenzae meningitis in Malaysia. ---
518  1998 Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. PRP, PRP-D, PRP-T
519  1998 Haemophilus influenzae type b disease and vaccination in Europe: lessons learned. ---
520  1998 Haemophilus influenzae type b infections in Hong Kong. CI
521  1998 Haemophilus influenzae type b polysaccharides-protein conjugate vaccine elicits a more diverse antibody repertoire in infants than in adults. PS
522  1998 Haemophilus influenzae type b vaccines: history, choice and comparisons. ---
523  1998 Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls. BMT
524  1998 Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations. DTaP
525  1998 Immunogenicity and safety of Haemophilus influenzae type b conjugate vaccine (HibTITER) and a combination vaccine of diphtheria, tetanus, pertussis and HibTITER (TETRAMUNE) in two-month-old infants. DTP
526  1998 Immunogenicity assays and surrogate markers to predict vaccine efficacy. ---
527  1998 Immunogenicity of a combined hepatitis B and Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. OMP, PRP
528  1998 Induction of cytokines and anti-cytokine autoantibodies in cerebrospinal fluid (CSF) during experimental bacterial meningitis. Aabs, CSF, IFN-gamma, p.i, TGF-beta, TNF-alpha
529  1998 Low genetic diversity of Haemophilus influenzae type b compared to nonencapsulated H. influenzae in a population in which H. influenzae is highly endemic. ncHi
530  1998 Mathematical models of Haemophilus influenzae type b. ---
531  1998 Measuring the impact of conjugate vaccines on invasive Haemophilus influenzae type b infection in Western Australia. ---
532  1998 Mucosal responses to parenteral and mucosal vaccines. eIPV, HBV, OPV
533  1998 Need for Haemophilus influenzae type b vaccination in Asia as evidenced by epidemiology of bacterial meningitis. ---
534  1998 Population-based study of the adequacy of well-child care services: a rural county's report card. ---
535  1998 Potential and limitations of polysaccharide vaccines in infancy. CPS
536  1998 Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccine. PRP, TT
537  1998 Preseptal and orbital cellulitis in childhood. A changing microbiologic spectrum. ---
538  1998 Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997. Hi
539  1998 Proposed vaccine information materials for hepatitis B, Haemophilus influenzae type b (Hib), Varicella (chickenpox), and measles, mumps, rubella (MMR) vaccines--CDC. Notice with comment period. MMR
540  1998 Protective immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children who failed to respond to prior invasive H. influenzae type b disease. ---
541  1998 Randomised controlled trial of combined diphtheria, tetanus, whole-cell pertussis vaccine administered in the same syringe and separately with Haemophilus influenzae type b vaccine at two, three and four months of age. DTPw, PM, PRP, SB
542  1998 Recent developments in bacterial conjugate vaccines. ---
543  1998 Recommended childhood immunization schedule--United States, 1998. AAFP, AAP, ACIP, MMR
544  1998 Reduced incidence of septic arthritis in children by Haemophilus influenzae type-b vaccination. Implications for treatment. ---
545  1998 Response to conjugate Haemophilus influenzae B vaccine among infants in Niamey, Niger. DTP, GMTs
546  1998 Role of kappa II-A2 light chain CDR-3 junctional residues in human antibody binding to the Haemophilus influenzae type b polysaccharide. Arg, CDR3, PS
547  1998 Safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB) in Papua New Guinean children. anti-PRP
548  1998 Study on Haemophilus influenzae type b diseases in China: the past, present and future. ---
549  1998 Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines. OD, PS
550  1998 Susceptibility and genetic relatedness of invasive Haemophilus influenzae type b in Italy. NTHi, PFGE
551  1998 Sustainable introduction of affordable new vaccines: the targeting strategy. GPV
552  1998 The epidemiology of Haemophilus influenzae type b carriage among infants and young children in Santo Domingo, Dominican Republic. ---
553  1998 The etiology of bacterial pneumonia and meningitis in Vietnam. ---
554  1998 The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease? ---
555  1998 The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group. PRP
556  1998 The introduction of Haemophilus influenzae type b immunization into the United Kingdom: practical steps to assure success. ---
557  1998 The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries. ---
558  1998 The new DTPw-HBV-Hib combination vaccine can be used at the who schedule with a monovalent dose of hepatitis B vaccine at birth. ---
559  1998 The rationale for population-based surveillance for Haemophilus influenzae type b meningitis. ---
560  1998 Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. CI, DTP
561  1998 [Epidemiology of Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae in children in the Valencia Community, Spain. Acute diseases study group]. VC
562  1998 [Epidemiology of invasive Hemophilus influenzae B infections in Bedouins and Jews; conjugate Hib vaccines]. ---
563  1998 [Haemophilus influenzae type b osteoarthritis. A report of 7 cases and a review of the literature]. URI
564  1998 [Invasive infection with Haemophilus influenzae type b in spite of complete vaccination]. HibTT
565  1998 [Sepsis caused by Haemophilus influenzae type B with septic arthritis in an infant]. ---
566  1998 [Vaccination against Haemophilus influenzae type b in the Valencia Community: efficacy and failure of vaccinations]. ---
567  1999 A case-control study of risk factors for Haemophilus influenzae type B disease in Navajo children. CI, OR
568  1999 A hierarchical Bayesian model to predict the duration of immunity to Haemophilus influenzae type b. ---
569  1999 A novel mechanism for cytokine regulation: screening, selection, and characterization of anticytokine monoclonal and polyclonal autoantibodies. AAb, CRC, IFN-gamma, mAab, TNF-alpha
570  1999 A randomised trial of a Haemophilus influenzae type b conjugate vaccine in a developing country for the prevention of pneumonia--ethical considerations. ---
571  1999 A routine high-performance size-exclusion chromatography to determine molecular size distribution of Haemophilus influenzae type b conjugate vaccines. ---
572  1999 Acute epiglottitis despite vaccination with haemophilus influenzae type B vaccine. ---
573  1999 Adverse effects and sero-responses to an acellular pertussis/diphtheria/tetanus vaccine when combined with Haemophilus influenzae type b vaccine in an accelerated schedule. ---
574  1999 Aetiology and clinical signs of bacterial meningitis in children admitted to Goroka Base Hospital, Papua New Guinea, 1989-1992. ---
575  1999 An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. DTaP, DTaP, EU, FHA, OPV, PRN, PT
576  1999 Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants. AI, CI, DTaP, HB, PS
577  1999 Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. ---
578  1999 Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae. rP40, TT
579  1999 Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis. HBV
580  1999 Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. DTP, Pa
581  1999 Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines. IgA, RRV-TV
582  1999 Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in Spain. CBA, Pta
583  1999 Decreased point prevalence of Haemophilus influenzae type b (Hib) oropharyngeal colonization by mass immunization of Brazilian children less than 5 years old with hib polyribosylribitol phosphate polysaccharide-tetanus toxoid conjugate vaccine in combination with diphtheria-tetanus toxoids-pertussis vaccine. PRP-T
584  1999 Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. DTP
585  1999 Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines? ---
586  1999 Effect of reminder notices on the timeliness of early childhood immunizations. DPT, MMR
587  1999 Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants. DTP, PS, TT
588  1999 Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. CI, OR
589  1999 Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. ---
590  1999 Epidemiology of bacterial meningitis. ---
591  1999 Epiglottitis in Sweden before and after introduction of vaccination against Haemophilus influenzae type b. ---
592  1999 Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine. DTaP
593  1999 Evaluation of serum levels of IgG subclasses and anti-ribosyl-ribitolphosphate IgG and IgG2 in children with Haemophilus influenzae b meningitis. anti-PRP
594  1999 Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines. PRP
595  1999 Fifteen years of experience with bacterial meningitis. ---
596  1999 Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide. OMPC, PRP
597  1999 Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine. ---
598  1999 IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Pnc PS
599  1999 Immune activation and virologic response to immunization in recent HIV type 1 seroconverters. ---
600  1999 Immunization and vaccine-preventable illness, United States, 1992 to 1997. ---
601  1999 Immunization schedule: dynamics and updating ---
602  1999 Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response. PRP
603  1999 Immunohistological characterization of leukocytes in the lungs of healthy mice and after bacterial intratracheal infection. BAL, CF
604  1999 Incidence of invasive pneumococcal disease in Sydney children, 1991-96. ---
605  1999 Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group. DT, EPI, OPV
606  1999 Infant vaccinations and risk of childhood acute lymphoblastic leukaemia in the USA. ALL, CI, RR
607  1999 Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates. ---
608  1999 Lack of association between early childhood immunizations and beta-cell autoimmunity. DTP
609  1999 Meningitis: causes, symptoms and signs and nursing management. ---
610  1999 Molecular epidemiological study of Haemophilus influenzae serotype b strains obtained from children with meningitis in Japan. PFGE, RAPD, RFLP
611  1999 Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models. DT, HibCP, TT
612  1999 National Surveillance System and Hib meningitis incidence in Italy. ---
613  1999 Natural Haemophilus influenzae type b capsular polysaccharide antibodies in 412 infants and children from West Africa (Burkina-Faso) and France: a cross-sectional serosurvey. ---
614  1999 New acellular pertussis-containing paediatric combined vaccines. aP, DTaP, FHA, IPV, PT
615  1999 New vaccine information materials for hepatitis B, Haemophilus influenzae type b (Hib), and varicella (chickenpox) vaccines, and revised vaccine information materials for measles, mumps, rubella (MMR) vaccines. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Notice. CDC, MMR
616  1999 Normal IgG and impaired IgM responses to polysaccharide vaccines in asplenic patients. ---
617  1999 Nucleotide sequences of genes coding for fimbrial proteins in a cryptic genospecies of Haemophilus spp. isolated from neonatal and genital tract infections. ---
618  1999 Oklahoma notes decline in Haemophilus influenzae: invasive Haemophilus influenzae disease among children aged < 5 years--Oklahoma, 1990-1997. Hi
619  1999 Paediatric epiglottitis: the influence of the Haemophilus influenzae b vaccine, a ten-year review in the Sheffield region. ---
620  1999 Pasteurella multocida meningitis in infancy - (a lick may be as bad as a bite). ---
621  1999 Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. ---
622  1999 Placental transfer of IgG antibodies against Haemophilus influenzae type b capsular polysaccharide in Brazilian term and preterm newborns. ---
623  1999 Prevention and therapy of bacterial infections for children with asplenia or hyposplenia. PSS
624  1999 Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. As-L, As-S, Co-S, DTaP
625  1999 Prophylaxis of bacterial meningitis. ---
626  1999 Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. ---
627  1999 Safety, tolerability and immunogenicity of a Haemophilus influenzae type b vaccine containing aluminum phosphate adjuvant administered at 2, 3 and 4 months of age. DPT, PRP
628  1999 Severe apnoeas following immunisation in premature infants. DPT
629  1999 Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines. DP
630  1999 Spectrum and burden of severe Haemophilus influenzae type b diseases in Asia. ---
631  1999 Strategies for the control of pneumococcal diseases. ---
632  1999 Structural requirements of the major protective antibody to Haemophilus influenzae type b. ---
633  1999 Studies on a Hib-tetanus toxoid conjugate vaccine: effects of co-administered tetanus toxoid vaccine, of administration route and of combined administration with an inactivated polio vaccine. IM, IPV, s.c
634  1999 The Hib immunization programme in the Oxford region: an analysis of the impact of vaccine administration on the incidence of disease. ---
635  1999 The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. GMC, PRP
636  1999 The influence of prematurity and low birthweight on transplacental antibody transfer in Sri Lanka. DT, HSV-1, MeV, PN, RSV, TT, VZV
637  1999 The pathogenic role of fimbriae of Haemophilus influenzae type b in murine bacteraemia and meningitis. PRP
638  1999 Use of Dorset egg medium for maintenance and transport of Neisseria meningitidis and Haemophilus influenzae type b. ---
639  1999 Vaccine, yes; injection, no: maternal responses to the introduction of Haemophilus influenzae type b (Hib) vaccine. ---
640  1999 [Circulating Haemophilus influenzae in Cuba. Characterization of strains isolated from meningitis]. ---
641  1999 [Estimation of vaccination rates in children of 10 months, 2 years and 4 years of age who underwent a health checkup at the Well Child Clinic in Paris during the year 1997]. DTPP
642  1999 [Haemophilus influenza type b invasive disease in the Community of Valencia. Study Group on Invasive Diseases]. Hi
643  1999 [Impact of vaccination against Haemophilus influenzae on the incidence of invasive infections from Haemophilus influenzae type B in the Nord-Pas-de-Calais region]. ---
644  1999 [Introduction of a conjugate vaccine against Hib in Chile and Uruguay]. ---
645  1999 [Vaccination against Haemophilus influenzae type b in Uruguay: experience and impact]. ---
646  2000 A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis. PS
647  2000 A model to estimate the probability of hepatitis B- and Haemophilus influenzae type b-vaccine uptake into national vaccination programs. HB
648  2000 A review of Hib epidemiology in Asia. ---
649  2000 Age- and cause-specific childhood mortality in Lombok, Indonesia, as a factor for determining the appropriateness of introducing Haemophilus influenzae type b and pneumococcal vaccines. ARI, CNS
650  2000 An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b. NMR
651  2000 Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. ---
652  2000 Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib. ---
653  2000 Back-calculating the age-specific incidence of recurrent subclinical Haemophilus influenzae type b infection. ---
654  2000 Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. ---
655  2000 Comparative evaluation of conjugate vaccines in the Haemophilus influenzae infection model. ---
656  2000 Conjugate pneumococcal vaccines for non-indigenous children in Australia. ---
657  2000 Dynamics of natural immunity caused by subclinical infections, case study on Haemophilus influenzae type b (Hib). ---
658  2000 Effect of fever on the serum antibody response of Gambian children to Haemophilus influenzae type b conjugate vaccine. ---
659  2000 Epidemiology of Haemophilus influenzae type b meningitis in Manila, Philippines, 1994 to 1996. CSF
660  2000 Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. ---
661  2000 Evaluation of vaccines to prevent childhood pneumonia: lessons relevant to planning tuberculosis vaccine trials. BCG
662  2000 Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage. ---
663  2000 Follow-up of Saudi children vaccinated with Haemophilus influenzae type B vaccine. GMTs, OPV
664  2000 Haemophilus influenzae type B (Hib) antibody responses in children given diphtheria-tetanus-acellular pertussis-Hib combination vaccines. ---
665  2000 Haemophilus influenzae type b and Streptococcus pneumoniae as causes of pneumonia among children in Beijing, China. ---
666  2000 Haemophilus influenzae type B disease, vaccines, and care of exposed individuals. ---
667  2000 Haemophilus influenzae type b still remains a leading cause of meningitis among unvaccinated children--a prospective CSF analysis study. CSF, SP
668  2000 Haemophilus influenzae type B vaccination and risk of childhood leukaemia in a vaccine trial in Finland. ---
669  2000 Haemophilus influenzae type b vaccination and risk of childhood leukemia in a vaccine trial in finland. ---
670  2000 Immunization coverage among predominantly Hispanic children, aged 2-3 years, in central Los Angeles. DT, HepB, HI, MMR, PPS, WIC
671  2000 Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine. DTaP, HepB
672  2000 Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. HI
673  2000 Impact of Haemophilus influenzae type b (Hib) conjugate vaccines on Haemophilus influenzae meningitis in Wisconsin. CII
674  2000 Interaction of fimbriae of Haemophilus influenzae type B with heparin-binding extracellular matrix proteins. FN, HB-GAM
675  2000 Invasive disease due to Haemophilus influenzae type b during the first six years of general vaccination of Swedish children. ---
676  2000 Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. ---
677  2000 Invasive Haemophilus influenzae type b infections in Singapore children: a hospital-based study. ---
678  2000 Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. IgA
679  2000 Non-infectious epiglottitis in children: two cases report. ---
680  2000 Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome. ED
681  2000 Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia. ---
682  2000 Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination. ---
683  2000 Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules. HB, SP
684  2000 Population-based surveillance for bacterial meningitis in the Dominican Republic: implications for control by vaccination. ---
685  2000 Population-based surveillance of Hib invasive infections in children in British Columbia Alberta and Ontario - 1995 to 1997. DPT-IPV, PRP-T
686  2000 Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections. DTaP-HBV-IPV
687  2000 Prospects for pneumococcal vaccination in African children. ---
688  2000 Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine. DTP, GMCs, PRP-T
689  2000 Suppression of macrophage activation with CNI-1493 increases survival in infant rats with systemic Haemophilus influenzae infection. IL-1beta, TNF-alpha
690  2000 Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine. CRM, ISS, TT
691  2000 The introduction of new vaccines into developing countries II. Vaccine financing. GNP, VPB
692  2000 Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children. ---
693  2000 Update on Haemophilus influenzae serotype b and meningococcal vaccines. ---
694  2000 Update: expanded availability of thimerosal preservative-free hepatitis B vaccine. ---
695  2000 Utility of the antibody response to a conjugated Haemophilus influenzae type B vaccine for diagnosis of primary humoral immunodeficiency. ---
696  2000 Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998. ABS, ACIR, AIHW, MMR, NNDSS, VPDs
697  2000 Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. ---
698  2000 [Epidemiologic aspects of Haemophilus influenzae type b infection]. ---
699  2000 [Rapid assessment of the impact of Haemophilus influenzae vaccine serotype b in Colombia. Public Health Laboratories]. ---
700  2000 [Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children]. NSCK
701  2001 A new combined DTP-HBV-Hib vaccine--strategy for incorporation of Hib vaccination into childhood immunisation programmes. DTP-HBV, EL, GMTs
702  2001 Acute epiglottitis in the tropics: is it an adult disease? ---
703  2001 Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. B-CLL, S. pneumoniae
704  2001 Assessing efficacy of Haemophilus influenzae type b combination vaccines. DTaP
705  2001 Bacterial meningitis in childhood at the Children's Hospital of Pittsburgh: 1988-1998. ---
706  2001 Bacterial meningitis in Saudi Arabia: the impact of Haemophilus influenzae type b vaccination. KFNGH
707  2001 Bacterial meningitis: current controversies in approaches to treatment. ---
708  2001 Burden of meningitis and other severe bacterial infections of children in africa: implications for prevention. ---
709  2001 Clinical relevance of lower Hib response in DTPa-based combination vaccines. DTPa
710  2001 Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in The Philippines. PHP
711  2001 Day-care and meningococcal disease in young children. ---
712  2001 Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of immune memory after combined diphtheria-tetanus-pertussis-polio-Haemophilus influenzae type b primary vaccination. DTPa, IPV, PRP
713  2001 Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM(197) conjugate vaccines. PRP
714  2001 Epidemiology of bacterial meningitis among children in Brazil, 1997-1998. PYs
715  2001 Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines. D.fim-PRP
716  2001 Haemophilus influenzae porin contributes to signaling of the inflammatory cascade in rat brain. IL-1alpha, MIP-2, TNF-alpha
717  2001 Haemophilus influenzae type b colonization in children in a hospital-based day care center. CMF-DCC, DCC
718  2001 Haemophilus influenzae Type b disease among Amish children in Pennsylvania: reasons for persistent disease. ---
719  2001 Haemophilus influenzae type b diseases in children: a pre-vaccination study. ---
720  2001 Haemophilus influenzae type b meningitis in the state of Parana, Brazil ---
721  2001 Haemophilus influenzae type b serology in childhood leukaemia: a case-control study. ALL
722  2001 Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses. ---
723  2001 Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process. ---
724  2001 Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody. IL, PS
725  2001 Immunogenicity and reactogenicity of diphtheria, tetanus and pertussis toxoids combined with inactivated polio vaccine, when administered concomitantly with or as a diluent for a Hib conjugate vaccine. DTaP-IPV
726  2001 Immunological characterization of conjugated Haemophilus influenzae type b vaccine failure in infants. Ig
727  2001 Impact of human immunodeficiency virus type 1 infection on the epidemiology and outcome of bacterial meningitis in South African children. CI, HIV-1, RR
728  2001 Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain. ---
729  2001 Imperfect memory and the development of Haemophilus influenzae type B disease. ---
730  2001 Meningitis and septicaemia in a child caused by non-typable Haemophilus influenzae biotype III. ---
731  2001 Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Hi
732  2001 Passive exposure to tobacco smoke and bacterial meningitis in children. CI, OR
733  2001 Physician credentials and practices associated with childhood immunization rates: private practice pediatricians serving poor children in New York City. DTP, MMR, PPAC
734  2001 Principles of pediatric combination vaccines and practical issues related to use in clinical practice. DTPa, HepB, IPV
735  2001 Rapid detection of Haemophilus influenzae type b in Bangladeshi children with pneumonia and meningitis by PCR and analysis of antimicrobial resistance. CSF, PCR
736  2001 Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines. TT
737  2001 Reactogenicity of DTPa-HBV/Hib vaccine administered as a single injection vs DTPa-HBV and Hib vaccines administered simultaneously at separate sites, to infants at 2, 4 and 6 months of age. ---
738  2001 Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. CLL
739  2001 Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. OMP, PnPs
740  2001 Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia. ---
741  2001 Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. DTP, GMTs
742  2001 Tetracel (American Home Products). AHP
743  2001 The adjuvant effect of synthetic oligodeoxynucleotide containing CpG motif converts the anti-Haemophilus influenzae type b glycoconjugates into efficient anti-polysaccharide and anti-carrier polyvalent vaccines. CHO, ISS, TT
744  2001 The numbers of leukocyte subsets in lung sections differ between intercellular adhesion molecule-1-/-, lymphocyte function-associated antigen-1-/- mice and intercellular adhesion molecule-1-/- mice after aerosol exposure to Haemophilus influenzae type-b. DCs, ICAM-1, LFA-1
745  2001 The WHO Vaccine Trial Registry. ETEC, RSV
746  2001 Vaccination rate and age of premature infants weighing <1500 g: a pilot study in north-western Switzerland. ---
747  2001 Vaccines against polysaccharide antigens. CPS, PS
748  2001 [Impact of vaccination against Haemophilus influenzae type b in Cuba]. ---
749  2001 [Specific characteristics of composition of synthetic nutrient media for cultivation of Hemophilus influenzae type b from the standpoint of bacterial metabolism]. ---
750  2002 A survey of vaccine coverage and antibiotic prophylaxis in splenectomised patients in Scotland. ---
751  2002 Are Haemophilus influenzae infections a significant problem in India? A prospective study and review. ---
752  2002 Characterization of haemophilus influenzae isolated from invasive disease in Brazil from 1990 to 1999. AM, CO
753  2002 Childhood vaccinations and risk of asthma. MMR
754  2002 Combinations of protein polysaccharide conjugate vaccines for intranasal immunization. inl, MenC
755  2002 Comparative trial to assess the reactogenicity of the diphtheria-tetanus-acellular pertussis (DTPa) vaccine plus Haemophilus influenzae type B (Hib) conjugate vaccine and that of the diphtheria-tetanus-whole cell pertussis (DTPw) vaccine plus Hib conjugate vaccine, administered in single injection a. DTPa, DTPw
756  2002 Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b. Dip, ELISAs, Tet
757  2002 Concentration and avidity of anti-Haemophilus influenzae type b (Hib) antibodies in serum samples obtained from patients for whom Hib vaccination failed. ---
758  2002 Detection of delayed vaccinations: a new approach to visualize vaccine uptake. KM
759  2002 Epidemiology of meningitis due to Haemophilus influenzae type b in children in Bulgaria: a prospective, population-based surveillance study. CSF
760  2002 Facial cellulitis in childhood: a changing spectrum. ---
761  2002 Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for response. CLL
762  2002 Haemophilus influenzae type b and cross-reactive antigens in natural Hib infection dynamics; modelling in two populations. CR
763  2002 Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: a randomized trial. DTP
764  2002 Haemophilus influenzae type b meningitis: how much better is prevention than cure? PNG
765  2002 Immunogenicity and reactogenicity of DTPw-HB/Hib vaccine administered to colombian infants after a birth dose of hepatitis B vaccine. ---
766  2002 Immunogenicity of anti-Haemophilus influenzae type b CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant. CRM, ISS, ODN, PRP
767  2002 Impact of a regional Hib vaccination programme in Italy. ---
768  2002 Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis. ---
769  2002 Intra-oral administration of sweet-tasting substances and infants' crying response to immunization: a randomized, placebo-controlled trial. DTP
770  2002 Lack of association between receipt of conjugate haemophilus influenzae type B vaccine (HbOC) in infancy and risk of type 1 (juvenile onset) diabetes: long term follow-up of the HbOC efficacy trial cohort. HbOC
771  2002 On technological and immunological benefits of multivalent single-injection microsphere vaccines. DT, ELISA, PT, TT
772  2002 Pharyngeal colonization with Haemophilus influenzae type b among healthy Turkish infants and children. DCC, ES, HCC
773  2002 Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines. CD, HPAEC-PAD, MenC, NMR
774  2002 Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine. HB
775  2002 Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998-2000. Hi
776  2002 Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection. ---
777  2002 Reemergence, in southwestern Alaska, of invasive Haemophilus influenzae type b disease due to strains indistinguishable from those isolated from vaccinated children. ET, PFGE
778  2002 Safety and immunogenicity of TETRActHIB (a vaccine combining DTP vaccine and Haemophilus influenzae type B conjugate vaccine) administered to infants at 6, 10 and 14 weeks of age. DTP, WHO EPI
779  2002 Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants. DTPa-HBV-IPV, OPV
780  2002 Serotyping discrepancies in Haemophilus influenzae type b disease--United States, 1998-1999. Hi
781  2002 The beneficial impact of Hib vaccine on disease rates in New Zealand children. Hi
782  2002 The new pneumococcal vaccine. ---
783  2002 The pneumococcus: carriage, disease and conjugate vaccines. ---
784  2002 The UK Hib vaccine experience. ---
785  2002 Vaccination against Haemophilus influenzae type b and atopy in east German schoolchildren. ---
786  2002 Vaccination coverage estimates by EPI cluster sampling survey of children (18-24 months) in Flanders, Belgium. DTP, HB, MMR
787  2002 Vaccination coverage of foreign-born children 19 to 35 months of age: findings from the National Immunization Survey, 1999-2000. ---
788  2002 Wheezing lower respiratory disease and vaccination of full-term infants. MMR
789  2002 [Young child with fever of unknown origin in the 'post Haemophilus influenzae era']. ---
790  2003 A causal association between Haemophilus influenzae type b (Hib) vaccine and diabetes. ---
791  2003 Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. ---
792  2003 Characterization of polysaccharide production of haemophilus influenzae Type b and its relationship to bacterial cell growth. DCW
793  2003 Childhood bacterial meningitis in Bulgaria: a population-based retrospective study in six regions during 1992-96. ---
794  2003 Combined hepatitis B vaccines. HepB, IPV, VHPB
795  2003 Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age. ---
796  2003 Conjugate vaccines--a breakthrough in vaccine development. ---
797  2003 Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learned. DTPa, IPV
798  2003 Differences in genetic and transcriptional organization of the glpTQ operons between Haemophilus influenzae type b and nontypeable strains. NTHi
799  2003 Effects of two pediatric vaccines on autoimmune diabetes in NOD female mice. DTaP-IVP, IDDM, NOD
800  2003 Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. ---
801  2003 Estimating the Haemophilus influenzae type b (Hib) disease burden and the impact of Hib vaccine in Fiji. CI, RAT, under-5s
802  2003 Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. EPI, WHO
803  2003 Feasibility study of the immunogenicity and safety of a novel DTPw/Hib (PRP-T) Brazilian combination compared to a licensed vaccine in healthy children at 2, 4, and 6 months of age. EPI
804  2003 Global burden of acute respiratory infections in children: implications for interventions. ARI
805  2003 Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. ---
806  2003 Haemophilus influenzae type B (HiB) is back. ---
807  2003 Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. ---
808  2003 Heptavalent pneumococcal conjugate vaccine: current and future impact. ---
809  2003 Hib vaccination in infants born prematurely. PRP
810  2003 High incidence of Haemophilus influenzae type b infection in children in Pacific island countries. PICs, RAT, WHO
811  2003 IGH V3-23*01 and its allele V3-23*03 differ in their capacity to form the canonical human antibody combining site specific for the capsular polysaccharide of Haemophilus influenzae type b. PS
812  2003 Immunization with Haemophilus influenzae (Hib) conjugate vaccine following discharge from hospital. ---
813  2003 Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure. GMC
814  2003 Impact of the Advisory Committee on Immunization Practices' 4-day grace period in a low-income community. ACIP, DTaP, HepB, MMR, VFC
815  2003 Increasing immunization coverage. American Academy of Pediatrics Committee on Community Health Services. American Academy of Pediatrics Committee on Practice and Ambulatory Medicine. DTaP, MMR
816  2003 Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. IgG1, PCP
817  2003 Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Hib-ab, PS
818  2003 Maternal immunization with Haemophilus influenzae type b vaccines in different populations. ---
819  2003 Meningitis and pneumonia in Guatemalan children: the importance of Haemophilus influenzae type b and Streptococcus pneumoniae. CSF
820  2003 Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide: expression of canonical variable regions and their variants in vaccinated infants. PS
821  2003 Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines? GBS, PS
822  2003 Paediatric acute epiglottitis: not a disappearing entity. ---
823  2003 Parental perception of educational, behavioural and general health problems in school-age survivors of bacterial meningitis. ---
824  2003 Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. ---
825  2003 Prospective, randomized comparison of OM-85 BV and a prophylactic antibiotic in children with recurrent infections and immunoglobulin A and/or G subclass deficiency. BPG, Ig, IVIG
826  2003 Response to immunization with measles, tetanus, and Haemophilus influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection and are treated with highly active antiretroviral therapy. HAART, HIV
827  2003 Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. ---
828  2003 Risk of Haemophilus influenzae type b meningitis in Polish children varies directly with number of siblings: possible implications for vaccination strategies. ---
829  2003 Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. DTaP-Hib
830  2003 Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants. GMC, lot 1, PCV, PS
831  2003 The 2001 serological survey in the Czech Republic--Hib invasive disease Haemophilus influenzae b. ---
832  2003 The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine. DTP, GMTs, OPV
833  2003 Vaccinations may induce diabetes-related autoantibodies in one-year-old children. ABIS
834  2003 Vaccine development for capsulate bacteria causing pneumonia. GBS, SP
835  2003 [Continuous occurrence of two cases of Haemophilus influenzae type b meningitis caused by different strains in a day nursery]. ---
836  2003 [Haemophilus influenzae type b: epidemiological situation in the State of Minas Gerais, Brazil, 1993-1997]. ---
837  2003 [Multilocus sequence-typing for characterization of Moscow strains of Haemophilus influenzae type b]. MLST, ST
838  2003 [Seroconversion after vaccination against pertussis, Haemophilus influenzae type b and poliomyelitis in preterm infants]. ---
839  2004 A phase IV open label study to assess the safety, tolerability and immunogenicity of a Haemophilus influenzae type B (Hib) CRM197 conjugated vaccine administered to healthy infants at 2, 4, and 6 months of age. ---
840  2004 A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. ---
841  2004 Acute hematogenous osteomyelitis in children: recognition and management. CA-MRSA
842  2004 Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster. ---
843  2004 Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccine. GMCs, PRP
844  2004 Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines. ---
845  2004 Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias. ---
846  2004 Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old. GMT
847  2004 Cellulitis resulting from infection by Haemophilus influenzae type b: report of two cases. ---
848  2004 Change in immunisation schedule and sudden infant death syndrome in Hungary. SIDS
849  2004 Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Ig, PIDD
850  2004 Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions. ---
851  2004 Clonal relationship of recent invasive Haemophilus influenzae serotype f isolates from Denmark and the United States. Hif
852  2004 Detection of Haemophilus influenzae type b by real-time PCR. ---
853  2004 Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines. ---
854  2004 Effect of dietary ribonucleotides on infant immune status. Part 1: Humoral responses. RMA
855  2004 Effectiveness of Haemophilus influenzae b conjugate vaccine on childhood pneumonia: a case-control study in Brazil. OR
856  2004 Endotoxin content in Haemophilus influenzae type b vaccine. ---
857  2004 Epidemiology of Haemophilus influenzae type b meningitis in Taiwan, 1997 and 2000. NHIRD
858  2004 Epiglottitis in the Hemophilus influenzae type B vaccine era: changing trends. ---
859  2004 Etiology of bacterial meningitis among children aged 2-59 months in Salvador, Northeast Brazil, before and after routine use of Haemophilus influenzae type B vaccine. BM, BMUE, CSF
860  2004 Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV Combination vaccine co-administered with a Hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age. IPV, Pa
861  2004 Four and one-half-year follow-up of the effectiveness of diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b and diphtheria-tetanus toxoids-acellular pertussis-inactivated poliovirus/H. influenzae type b combination vaccines in Germany. CI, DTaP, VE
862  2004 Generation of murine monoclonal antibodies to Haemophilus influenzae type b capsular polysaccharide by in vivo immunization. PRP, PRP-T
863  2004 Getting it right--the Australian Childhood Immunisation Register and immunisation rates in south-eastern Sydney. ---
864  2004 Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages. IL-6, LPS, TLRs, TNF-alpha
865  2004 Haemophilus influenzae type b conjugate vaccines. PRP
866  2004 Haemophilus influenzae type b infection in children in Pacific countries. RAT
867  2004 Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. HEK, KO, OMPC, PS, TLR2
868  2004 Human memory B cells transferred by allogenic bone marrow transplantation contribute significantly to the antibody repertoire of the recipient. BMT
869  2004 Impact of Haemophilus influenzae type b (Hib) vaccination on Hib meningitis in children in Far North Queensland, 1989 to 2003. ---
870  2004 Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina. CSF
871  2004 Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children. CSF
872  2004 Indirect protection obtained by Haemophilus influenzae type b vaccination: analysis in a structured population model. ---
873  2004 Infant immunization and the occurrence of atopic disease in Dutch and German children: a nested case-control study. BCG
874  2004 Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. ALL
875  2004 Introducing new vaccines in developing countries: concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease. ---
876  2004 Invasive Haemophilus influenzae type b infections in children in Paraguay. ---
877  2004 Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. ---
878  2004 Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator. SBA
879  2004 Meningococcal conjugate vaccines. ---
880  2004 Modelling transmission, immunity and disease of Haemophilus influenzae type b in a structured population. ---
881  2004 Natural immunity to Haemophilus influenzae type B in children of Ankara, Turkey. ---
882  2004 Naturally acquired immunity to Haemophilus influenzae type B in healthy Cuban children. ---
883  2004 Outbreak of Haemophilus influenzae type b disease among fully vaccinated children in a day-care center. ---
884  2004 Pneumonia in children in the developing world: new challenges, new solutions. ---
885  2004 Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand. ---
886  2004 Rapid assessment tool for Haemophilus influenzae type b disease in developing countries. ---
887  2004 Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life. CI, GMAI, GMC
888  2004 Review panel on Haemophilus influenzae type b (Hib) disease burden in Bangladesh, Indonesia and other Asian countries, Bangkok, 28-29 January 2004. ---
889  2004 Risk factors for invasive disease among children in Spain. aOR, CI
890  2004 Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population. Ig, PRP-D
891  2004 Safety and immunogenicity of two Haemophilus influenzae type b conjugate vaccines. ELISAs, PRP, WHO
892  2004 Subnormal immunity to Hemophilus influenzae type b (Hib) in previously vaccinated human immunodeficiency virus-infected children 59 months of age or older and response to booster doses of the conjugate vaccine. ---
893  2004 Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine. TCI
894  2004 T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination. ---
895  2004 The acceptance of three simultaneous vaccine injections recommended at 12 months of age. MenCCV, MMR
896  2004 The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. AT
897  2004 Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. ---
898  2004 Use of vaccine trials to estimate burden of disease. ---
899  2004 [Haemophilus influenzae meningitis in a child with complete immunisation]. ---
900  2004 [Impact of Haemophilus influenzae b (Hib) vaccination on meningitis in Central Brazil]. ---
901  2004 [Streptococcus pneumoniae and Haemophilus influenzae serotype B invasive disease. A 12-year retrospective study]. CSF
902  2004 [Successful treatment of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae type b meningitis with high-dose ceftriaxone administration]. BLNAR, CTRX, CTX
903  2004 [Vaccination for HIV positive travelers]. ---
904  2005 Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland. RR
905  2005 Acute osteomyelitis and septic arthritis in children. AHO, MRSA, SA
906  2005 Advances in pneumococcal vaccines: advantages for infants and children. PCVs
907  2005 Antibodies against Haemophilus influenzae type b capsular polysaccharide and tetanus toxoid before and after a booster dose of the carrier protein nine years after primary vaccination with a protein conjugate vaccine. CPS, DT, TT
908  2005 Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines. AB, HBV, IPV, NICU, Pa
909  2005 Assessment of sociodemographic factors and socio-economic status affecting the coverage of compulsory and private immunization services in Istanbul, Turkey. DPT, EPI, MMR, OPV
910  2005 Bacterial meningitis in children: critical review of current concepts. ---
911  2005 Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine. ---
912  2005 Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children. CRO, CSF, CTX, MICs, NMen, Spn
913  2005 Clinical and epidemiological implications of meningococcal disease. ---
914  2005 Development of a high-resolution magic-angle spinning nuclear magnetic resonance identity assay of the capsular polysaccharide from Haemophilus influenzae type b present in cetavlon precipitate. ---
915  2005 Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. ---
916  2005 Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003. Hia, PFGE, WMA
917  2005 Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease. ICD
918  2005 Frequent Haemophilus influenzae type B colonization in rural Thailand. ---
919  2005 Immunogenicity and Reactogenicity following Primary Immunisation with a Combined DTaP-HBV Vaccine and a Haemophilus influenzae Type B Vaccine Administered by Separate or Mixed Injection. PRP
920  2005 Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial. CI, DTwP, MenC, SBT
921  2005 Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age. PCV
922  2005 Immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b in Asian infants born in the United Kingdom. GMT
923  2005 Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. ---
924  2005 Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. DTP
925  2005 Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands. MLST, MLVA
926  2005 Invasive Haemophilus influenzae type b disease in Sweden 1997-2003: epidemiological trends and patterns in the post-vaccine era. ---
927  2005 Invasive Haemophilus influenzae type B diseases in Bangladesh, with increased resistance to antibiotics. CSF, LA
928  2005 Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003. ---
929  2005 Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine. Hi
930  2005 Presence of multiple copies of the capsulation b locus in invasive Haemophilus influenzae type b (Hib) strains isolated from children with Hib conjugate vaccine failure. TVF
931  2005 Prevention of Haemophilus influenzae type b disease: past success and future challenges. ---
932  2005 Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB. NMR, RSD
933  2005 Streptococcus pneumoniae and Haemophilus influenzae type B Carriage, Central Asia. ---
934  2005 Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model. DTaP, IPV, PRP
935  2005 Surveillance of natural acquired antibodies to Haemophilus influenzae type b among children in Cairo-Egyptian. ---
936  2005 The burden of pneumonia in children: an Australian perspective. RSV
937  2005 Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS). AE, DTaP, VAERS
938  2005 Transient Haemophilus influenzae type b bacteremia in a healthy child. S. pneumoniae
939  2005 Vaccination history and risk of childhood leukaemia. ---
940  2005 Vaccine information statements. Revolutionary but neglected educational advances in healthcare in the United States. CDC, DTaP, MMR, NVICP, Td, VAERS, VISs
941  2005 [Conjugated vaccines]. ---
942  2005 [Does vaccination cause disease?]. ---
943  2005 [Increase in the number of invasive Haemophilus influenzae type b infections]. ---
944  2005 [Non-typable Haemophilus influenzae severe pneumonia in an infant: case report]. ---
945  2005 [Oropharyngeal carriers in Venezuelan children in two child care settings, vaccinated or not with Haemophilus influenzae type b tetanus toxoid conjugate vaccine (PRP-T)]. ---
946  2005 [Skin and soft tissue infections caused by Haemophilus influenzae type b over a 30 year period]. ---
947  2005 [Study on Haemophilus influenzae type b: data from autopsy of community acquired pneumonia among children]. CAP, ISPCR
948  2005 [Validation of an ELISA assay for the quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide]. ---
949  2006 A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America. PRP, WHO
950  2006 Acute bacterial meningitis in Qatar. GBS, STP
951  2006 An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States. DTP, DTPH, NDs, TCVs, VAERS
952  2006 Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia - implications for vaccination strategies. ALL, TT
953  2006 Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: a 2-year hospital-based study. ABM, CFR, CSF, Hi, Nm, S. aureus, SP
954  2006 Changes in the epidemiology of epiglottitis following introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in England: a comparison of two data sources. ---
955  2006 Detection of antigenuria for diagnosis of invasive Haemophilus influenzae type b disease. LA
956  2006 Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation. ---
957  2006 Effect of dietary nucleotide supplementation on growth and immune function in term infants: a randomized controlled trial. nt, RCT
958  2006 Effect of probiotics on vaccine antibody responses in infancy--a randomized placebo-controlled double-blind trial. ---
959  2006 Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. HIV
960  2006 Effects of CNI-1493 on human granulocyte functions. fMLP, IFN-gamma, iNOS, LPS, NO, ROS
961  2006 Efficacy of Haemophilus influenzae type b vaccination of children: a meta-analysis. OR
962  2006 Epidemiology and outcome of bacterial meningitis in Canadian children: 1998-1999. ICU
963  2006 Genetic and phenotypic characterization of Haemophilus influenzae type b isolated from children with meningitis and their family members in Vietnam. CSF, PFGE
964  2006 Genetic diversity of invasive strains of Haemophilus influenzae type b before and after introduction of the conjugate vaccine in Italy. ---
965  2006 Haemophilus influenzae Type B (Hib). ---
966  2006 Haemophilus influenzae type b and pertussis vaccinations in preterm infants. ---
967  2006 Haemophilus influenzae type B meningitis among children in Hanoi, Vietnam: epidemiologic patterns and estimates of H. Influenzae type B disease burden. ---
968  2006 Haemophilus influenzae type b reemergence after combination immunization. CI, DTaP-Hib
969  2006 Haemophilus influenzae type b vaccination and reported atopic disorders in 8-12-year-old children. CI, DTP-IPV
970  2006 Haemophilus influenzae type b vaccination: long-term protection. ---
971  2006 Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model. DTaP
972  2006 Immunisation status of children in Germany: temporal trends and regional differences. MMR
973  2006 Immunogenicity and reactogenicity to Haemophilus influenzae type B (Hib) conjugate vaccine among rural Alaska adults. HbOC
974  2006 Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. DTP, PRP
975  2006 Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine. MMR
976  2006 Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska. IgG, SBA
977  2006 Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. HIV
978  2006 Kinetics of adaptive immunity to Haemophilus influenzae type b meningitis in transgenic mice: evidence from diverse expression of double T1/T2 transgenes and Th1/Th2-related cytokines. hThy1, mThy1.1
979  2006 Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. ALL
980  2006 Molecular epidemiology of Haemophilus influenzae type b causing vaccine failures in the United Kingdom. ---
981  2006 Natural and vaccine-induced immunity against Haemophilus influenzae type b in patients with beta-thalassemia. ---
982  2006 Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. DTPw, PRP
983  2006 Safety and immunogenicity of a new fully liquid DTPw-HepB-Hib combination vaccine in infants. ---
984  2006 Structural requirements for proinflammatory activity of porin P2 Loop 7 from Haemophilus influenzae. MAPK
985  2006 The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan. ABC
986  2006 The effect of zinc supplementation during pregnancy on immune response to Hib and BCG vaccines in Bangladesh. BCG, DTP, LBW
987  2006 The epidemiology of Haemophilus influenzae type b meningitis in Burkina Faso. ---
988  2006 The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence. HIV
989  2006 The use of combination vaccines has improved timeliness of vaccination in children. ---
990  2006 [Acute fever in infants]. ---
991  2006 [Invasive infections caused by Haemophilus influenzae type b after the institution of the conjugated vaccine on the expanded programm on immunization in Chile]. ---
992  2006 [The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia]. ---
993  2007 A population-based study of hospital admission incidence rate and bacterial aetiology of acute lower respiratory infections in children aged less than five years in Bangladesh. ALRIs, CYO, Spn
994  2007 A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. BMT, IPV, Td
995  2007 A study of physico-chemical interactions between Haemophilus influenzae type b and meningococcus group C conjugate vaccines. MenC, SEC
996  2007 Bacterial meningitis: the impact of vaccination. ---
997  2007 Computer-assisted 2-D agarose electrophoresis of Haemophilus influenzae type B meningitis vaccines and analysis of polydisperse particle populations in the size range of viruses: a review. ---
998  2007 Dr vicente verez bencomo, director, center for the study of synthetic antigens, university of havana. ---
999  2007 Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya. DALY
1000  2007 Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis. DALYs, ICER
1001  2007 Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. CI
1002  2007 Epidemiology of childhood meningitis in Kuwait. ---
1003  2007 Epidemiology of invasive Haemophilus influenzae type b disease in Singapore children, 1994-2003. ---
1004  2007 Failure to respond to hepatitis B vaccine in children with celiac disease. CD, HBV
1005  2007 Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil. ---
1006  2007 Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda. ---
1007  2007 Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. ---
1008  2007 Immunization histories given by adult caregivers accompanying children 3-36 months to the emergency department: are their histories valid for the Haemophilus influenzae B and pneumococcal vaccines? ED, PCP
1009  2007 Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy. aP, CI, GMCs, wP
1010  2007 Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine. DTPa, IPV, PRP, SBA
1011  2007 Impact of the Haemophilus influenzae type b vaccination program on HIB meningitis in Brazil. RF
1012  2007 Incidence of bacterial meningitis in Asia using enhanced CSF testing: polymerase chain reaction, latex agglutination and culture. CSF, LA, PCR-EIA, SP
1013  2007 Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax). FDA
1014  2007 Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years. ---
1015  2007 Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001. IMPACT
1016  2007 Low-income minority mothers' reports of infant health care utilisation compared with medical records. DTP
1017  2007 Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. CFR, IR, MR
1018  2007 National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2006. DTaP, HepB, MMR, NIS, PCV, VAR
1019  2007 Preventable infectious diseases using vaccination in developmental age in the province of Frosinone, Italy. ---
1020  2007 Prevention of bacterial meningitis: an overview of Cochrane systematic reviews. ABM, MCC
1021  2007 Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines. DTPa, DTPw
1022  2007 Quantitative measurements of Hemophilus influenzae type b capsular polysaccharide antibodies in Japanese children. anti-CP
1023  2007 Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba. DPT, IPV, OPV
1024  2007 Re-emergence of Haemophilus influenzae type b (Hib) disease in The Gambia following successful elimination with conjugate Hib vaccine. ---
1025  2007 Reduced anti-PRP antibody response to Hib immunisation in preterm (<32 weeks) UK infants who received inactivated polio (eIPV). eIPV, OPV
1026  2007 Responses to immunisation with Hib conjugate vaccine in Australian breastfed and formula-fed infants. ---
1027  2007 Revaccination of children after completion of standard chemotherapy for acute leukemia. GMC, GMT
1028  2007 Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. GMC, GMT, HSCT
1029  2007 Steroids for bacterial meningitis in children? ---
1030  2007 The influence of maternal immunization on infant immune responses. ---
1031  2007 The promise of conjugate vaccines for Africa. PS
1032  2007 Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. ---
1033  2007 [Two cases of meningitis caused by the same Haemophilus influenzae type B strain in a nursery at a 3-month interval]. ---
1034  2008 A prospective study of etiology of childhood acute bacterial meningitis, Turkey. CSF
1035  2008 Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda. ---
1036  2008 Acute childhood bacterial meningitis in Luanda, Angola. ---
1037  2008 Bacterial meningitis following introduction of Hib conjugate vaccine in northern Uganda. CSF
1038  2008 Behaviour is not really at risk after surviving meningitis in childhood. BM
1039  2008 Burden of invasive disease caused by Haemophilus influenzae type b (Hib) in Africa. five in one
1040  2008 Childhood bacterial meningitis in Ibadan, Nigeria--antibiotic sensitivity pattern of pathogens, prognostic indices and outcome. UCH
1041  2008 Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines. DTPw, GSK, PRP
1042  2008 Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008. ---
1043  2008 Cost-benefit analysis of haemophilus influenzae type B immunization in Korea. ---
1044  2008 Detection of Haemophilus influenzae type B DNA in a murine pneumonia model by in situ PCR. IS-PCR
1045  2008 Diagnosis and management of supraglottitis (epiglottitis). ---
1046  2008 Direct detection of the multidrug resistance genome of Haemophilus influenzae in cerebrospinal fluid of children: implications for treatment of meningitis. ICEs, MDR
1047  2008 Dr vicente verez bencomo, director, center for the study of synthetic antigens, university of havana. ---
1048  2008 DTaP-IPV/Hib vaccine (Pentacel). PRP-T
1049  2008 Epidemiology and outcomes of bacterial meningitis in Mexican children: 10-year experience (1993-2003). ---
1050  2008 Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005. Hia
1051  2008 Equity and child-survival strategies. IMCI
1052  2008 Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. PCTs
1053  2008 Four is better than nine. a combined diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b vaccine for routine immunization in Malaysia. HBV
1054  2008 Haemophilus influenzae type b antibodies in vaccinated and non-vaccinated children. anti-PRP, ELISA, GMT
1055  2008 Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study. CI
1056  2008 Haemophilus influenzae type b conjugate vaccine use and effectiveness. ---
1057  2008 Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. PRP
1058  2008 Immunogenicity and safety of two different Haemophilus influenzae type b conjugate vaccines in Korean infants. ELISA
1059  2008 Immunoglobulin G avidities in infants in Mexico after primary immunization with three doses of polyribosylribitol phosphate-tetanus toxoid Haemophilus influenzae type b vaccine. ---
1060  2008 Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic. ---
1061  2008 Incidence of Haemophilus influenzae type b meningitis in India. ---
1062  2008 Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. aP, HBV
1063  2008 Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. ---
1064  2008 Pathophysiological changes of gram-negative bacterial infection can be reproduced by a synthetic peptide mimicking loop L7 sequence of Haemophilus influenzae porin. sE-selectin, tPA, vWF
1065  2008 Periorbital cellulitis in the era of Haemophilus influenzae type B vaccine: predisposing factors and etiologic agents in hospitalized children. ---
1066  2008 Placental transfer of Haemophilus influenzae type b antibodies in malnourished pregnant women. CB, MN, PRP
1067  2008 Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries--worldwide, 2004-2007. ---
1068  2008 Revaccination does not improve an observed deficit in antibody responses in Pakistani adults born of a lower birth weight. ---
1069  2008 School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom. CI, MLST
1070  2008 Sustaining immunity after immunization against encapsulated bacteria. ---
1071  2008 The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries. DCVMN, HepB, NVI, OECD
1072  2008 The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines. ---
1073  2008 Trends in invasive Haemophilus influenzae type B disease in Australia, 1995-2005. ---
1074  2008 Two variants among Haemophilus influenzae serotype b strains with distinct bcs4, hcsA and hcsB genes display differences in expression of the polysaccharide capsule. ---
1075  2008 Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom. ---
1076  2008 Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. ---
1077  2008 Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia. ---
1078  2008 Vaccines to prevent pneumonia and improve child survival. ---
1079  2008 [Haemophilus influenzae b among bacterial meningitis in Bamako (2002-2004)]. EPI, INRSP
1080  2008 [Haemophilus influenzae type b--active prevention]. ---
1081  2008 [Hib vaccine]. ---
1082  2008 [Meningitis and encephalitis in Poland in 2006]. ---
1083  2008 [Severe Haemophilus influenzae b infection in healthy male adult]. ---
1084  2008 [Surveillance of Haemophilus Influenzae meningitis in children in France, 2001-2006]. Hi
1085  2009 Acute epiglottitis in Iceland 1983-2005. ---
1086  2009 Addition of isovitalex in chocolate agar for the isolation of Haemophilus influenzae. CA, CA-IVX, IVX
1087  2009 An audit of immunisation status of sickle cell patients in Coventry, UK. MenC
1088  2009 Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom. PRP
1089  2009 Antibody response to polysaccharide conjugate vaccines after nonmyeloablative allogeneic stem cell transplantation. allo-RIST, TT
1090  2009 Basis for immunization recommendations among countries of the worldHealth Organization European region. WHO
1091  2009 Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. ---
1092  2009 Burden of invasive disease caused by Haemophilus influenzae type b in Asia. ---
1093  2009 Childhood bacterial respiratory diseases: past, present, and future. ---
1094  2009 Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). CENTRAL, DTP, IPV, OPV
1095  2009 Community effect of Haemophilus influenzae type b vaccination in India. ---
1096  2009 Comparative impact assessment of child pneumonia interventions. ---
1097  2009 Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature. ---
1098  2009 Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers. HB, HBIG, HBsAg, HBV
1099  2009 Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States. ---
1100  2009 Etiologies of bacterial meningitis in Bangladesh: results from a hospital-based study. ---
1101  2009 Fever without localizing signs in children: a review in the post-Hib and postpneumococcal era. ---
1102  2009 Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection. PRP
1103  2009 Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa. ---
1104  2009 Hib epiglottitis despite fully vaccinated status. ---
1105  2009 Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination. ALL
1106  2009 Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom. GMCs, IgG, MCC, PRP, SBA
1107  2009 Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants. GMCs, MnCC
1108  2009 Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. ---
1109  2009 Invasive Haemophilus influenzae infections in Germany: impact of non-type b serotypes in the post-vaccine era. ---
1110  2009 Invasive Haemophilus influenzae Type B disease in five young children--Minnesota, 2008. MDH
1111  2009 Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine. ACIP, FDA, PRP
1112  2009 Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom. IQR
1113  2009 NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India. NTAGI, UIP
1114  2009 Pattern of functional antibody activity against Haemophilus influenzae type B (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine. PRP
1115  2009 Pediatric bacterial meningitis surveillance - African region, 2002--2008. PBM, WHO
1116  2009 Prevalence of oropharyngeal colonization by Haemophilus influenzae type b in Iranian children. ---
1117  2009 Prevention of meningococcal serogroup C disease by NeisVac-C. ---
1118  2009 Progress in timely vaccination coverage among children living in low-income households. MMR
1119  2009 Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. wtOMV
1120  2009 Recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. ---
1121  2009 Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. IPV
1122  2009 Safety and immunogenicity of an indigenously developed Haemophilus influenzae type b conjugate vaccine through various phases of clinical trials. NRA, SIIL
1123  2009 Sequelae due to bacterial meningitis among African children: a systematic literature review. IQR
1124  2009 Surveillance of acute bacterial meningitis among children admitted to a district hospital in rural Mozambique. ABM, CSF
1125  2009 Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: reinstatement of the booster dose at ages 12-15 months. AAFP, AAP, ACIP
1126  2009 [Corticosteroids in children with bacterial meningitis: indications and administration]. BM, DXM
1127  2010 A systematic review and critical evaluation of invasive Haemophilus influenzae type B disease burden studies in Asia from the last decade: lessons learned for invasive bacterial disease surveillance. ---
1128  2010 Accelerating policy decisions to adopt haemophilus influenzae type B vaccine: a global, multivariable analysis. GAVI Alliance
1129  2010 Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. aPV, FHA, GMC, HBV, IgG PT, PRN, PT
1130  2010 Association between single-nucleotide polymorphisms in Mal/TIRAP and interleukin-10 genes and susceptibility to invasive haemophilus influenzae serotype b infection in immunized children. SNPs
1131  2010 Association of secondhand smoke exposure with pediatric invasive bacterial disease and bacterial carriage: a systematic review and meta-analysis. CI, IBD, N. meningitidis, ORs, S. pneumoniae, SHS
1132  2010 Booster vaccination after neonatal priming with acellular pertussis vaccine. aP, DT, HBV, IPV
1133  2010 Burden of Haemophilus influenzae type b disease in Pakistani children. ---
1134  2010 Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage --- National Immunization Survey, United States, 2009. ACIP, NIS
1135  2010 Characterization of nontypeable Haemophilus influenzae collected from respiratory infections and invasive disease cases in Manitoba, Canada. NTHi
1136  2010 Chronic hip pain in a boy with mental retardation and cerebral palsy. ---
1137  2010 Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post-vaccination era. ---
1138  2010 Defining the correctness of a diagnosis: differential judgments and expert knowledge. ---
1139  2010 Diagnosis of Streptococcus pneumoniae and Haemophilus influenzae type b meningitis by identifying DNA from cerebrospinal fluid-impregnated filter paper strips. CSF, Pnc
1140  2010 DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination. ---
1141  2010 Estimating the vaccine-preventable burden of hospitalized pneumonia among young Mozambican children. ---
1142  2010 Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization. DTPw, EPI, HepB, OPV
1143  2010 Factors affecting the introduction of new vaccines to poor nations: a comparative study of the Haemophilus influenzae type B and hepatitis B vaccines. AFRO, HepB, QCA
1144  2010 Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines. ---
1145  2010 Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. ---
1146  2010 Global routine vaccination coverage, 2009. BCG, DTP, GIVS, HepB, MCV, PCV, WHO
1147  2010 Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions. ---
1148  2010 Global use of Haemophilus influenzae type b conjugate vaccine. ---
1149  2010 Glycoconjugate vaccines and immune interference: A review. DT, TT
1150  2010 Haemophilus influenza type b (Hib) vaccine and its carrier proteins. ---
1151  2010 Haemophilus influenzae serotype e meningitis in an adult. Hie
1152  2010 Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines. ART, HibCV
1153  2010 Haemophilus meningitis in an African neonate: time for active surveillance and institution of appropriate control measure. NPI
1154  2010 Haemophilusinfluenzae type b conjugate vaccine for preventing pneumonia in infants hospitalized for bronchiolitis: a case-control study. HibCV
1155  2010 Hospital surveillance of childhood bacterial meningitis in Senegal and the introduction of Haemophilus influenzae type b conjugate vaccine. ---
1156  2010 Immunogenicity of Haemophilus influenzae type b conjugate vaccines in Korean infants: a meta-analysis. CI, PRP
1157  2010 Incidence of childhood Haemophilus influenzae type b meningitis in Sri Lanka. CSF
1158  2010 Increasing immunization coverage. DTaP, HBV, IPV, MMR
1159  2010 Invasive Haemophilus influenzae Disease, Europe, 1996-2006. ncHi
1160  2010 Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. MCC, PRP, SBA
1161  2010 Knowledge of interim recommendations and use of Hib vaccine during vaccine shortages. ---
1162  2010 Long-term complications and risk of other serious infections following invasive Haemophilus influenzae serotype b disease in vaccinated children. IRR
1163  2010 Low serum serotype-specific pneumococcal antibody concentrations in young children with Haemophilus influenzae serotype b (Hib) vaccine failure. ---
1164  2010 Methodology and measurement of the effectiveness of Haemophilus influenzae type b vaccine: systematic review. VE
1165  2010 Naturally fluctuating low incidence of invasive pneumococcal infections not affected by large-scale haemophilus influenzae type B vaccination. ---
1166  2010 Pediatric disease burden and vaccination recommendations: understanding local differences. HepB, WHO
1167  2010 Poor clinical outcome for meningitis caused by Haemophilus influenzae serotype A strains containing the IS1016-bexA deletion. ---
1168  2010 Presence of multiple copies of capsulation loci in invasive Haemophilus influenzae type b (Hib) strains in Japan before introduction of the Hib conjugate vaccine. ---
1169  2010 Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. PRP
1170  2010 Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial. DTPw, HBV, OPV, PRP
1171  2010 Proteomic analysis of human U937 cell line activation mediated by Haemophilus influenzae type b P2 porin and its surface-exposed loop 7. LPS, OMPs
1172  2010 Responses to a conjugate pneumococcal vaccine in preterm infants immunized at 2, 3, and 4 months of age. ELISA, GMCs
1173  2010 Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines--United States, 2007-2008. Epi-X, PRRs, VAERS
1174  2010 Single versus multi-dose vaccine vials: an economic computational model. BCG, MEA, YF
1175  2010 Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa). ---
1176  2010 Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience. ---
1177  2010 Supraglottitis in the era following widespread immunization against Haemophilus influenzae type B: evolving principles in diagnosis and management. ICU
1178  2010 Susceptibility to invasive bacterial infections in children with sickle cell disease. IBI, SCD
1179  2010 The causative organisms of bacterial meningitis in Korean children in 1996-2005. ---
1180  2010 The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. cRCTs, LiST, PC
1181  2010 The Elimination of Haemophilus influenzae type b meningitis following conjugate vaccine introduction in Senegal. ---
1182  2010 Universal immunization of infants against Neisseria meningitidis: addressing the remaining unmet medical need in the prevention of meningitis and septicemia. ---
1183  2010 Vaccine responsiveness in premature infants. Men C, PNC
1184  2010 [Acute epiglottitis in Iceland from 1983-2005]. ---
1185  2010 [Evolution of vaccine coverage from school year 2003-2004 to 2006-2007, for 5 to 6-year-old children in Geneva]. MMR
1186  2010 [Factors associated with willingness to undergo vaccination against haemophilus influenzae type B (Hib)]. HBM, WTP
1187  2010 [Isolated congenital asplenia--a rare cause of severe pneumococcal sepsis]. Spn
1188  2010 [Meningitis and encephalitis in Poland in 2008]. ---
1189  2011 A DTaP-IPV//PRP∼T vaccine (Pentaxim): a review of 16 years' clinical experience. aP
1190  2011 A mixture of three prebiotics does not affect vaccine specific antibody responses in healthy term infants in the first year of life. lcFOS, pAOS, scGOS
1191  2011 Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type B vaccine experience. GAVI
1192  2011 Acute bacterial meningitis in infants and children: epidemiology and management. ABM
1193  2011 Bacterial and fungal meningitis and antimicrobial susceptibility pattern in Tikur Anbessa University Hospital, Addis Ababa, Ethiopia. CSF
1194  2011 Bacterial meningitis in the United States, 1998-2007. CI, GBS
1195  2011 Brainstem abscess caused by Haemophilus influenza and Peptostreptococcus species. ---
1196  2011 Changes in serotype distribution of Haemophilus influenzae meningitis isolates identified through laboratory-based surveillance following routine childhood vaccination against H. influenzae type b in Brazil. NTHi
1197  2011 Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States. DTaP-HepB-IPV, GMC, Hib-TT
1198  2011 Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines. ---
1199  2011 Comparative effects of carrier proteins on vaccine-induced immune response. ---
1200  2011 Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom's macroglobulinemia, and monoclonal gammopathy of undetermined significance. MGUS, MM, WM
1201  2011 County-level trends in vaccination coverage among children aged 19-35 months - United States, 1995-2008. DTaP, MMR, NIS
1202  2011 Coverage and causes of missed Haemophilus influenzae type B vaccination in urban and rural areas of Peshawar. ---
1203  2011 Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008. ---
1204  2011 Early acquisition and high nasopharyngeal co-colonisation by Streptococcus pneumoniae and three respiratory pathogens amongst Gambian new-borns and infants. NP
1205  2011 Effectiveness of haemophilus influenzae type B conjugate vaccine for prevention of meningitis in Senegal. ---
1206  2011 Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing countries--a review. GAVI Alliance, HIV, PCV, RSV
1207  2011 Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. ---
1208  2011 Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India. GAVI, WHO
1209  2011 Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral. ---
1210  2011 Haemophilus influenzae type b carriage and novel bacterial population structure among children in urban Kathmandu, Nepal. MLST, OPD, ST6, STs
1211  2011 Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras. NT
1212  2011 Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers. ---
1213  2011 High rates of colonization with drug resistant hemophilus influenzae type B and Streptococccus Pneumoniae in unvaccinated HIV infected children from West Bengal. ART
1214  2011 Hypothesis: conjugate vaccines may predispose children to autism spectrum disorders. ASDs
1215  2011 Immunogenicity and reactogenicity of DTPa-IPV/Hib vaccine co-administered with hepatitis B vaccine for primary and booster vaccination of Taiwanese infants. ---
1216  2011 Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants. GMTs, HBsAg, PCV, SPR
1217  2011 Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age. DTaP, HAV
1218  2011 Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants. MenC, MenY
1219  2011 Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. NTHi
1220  2011 Loop-mediated isothermal amplification assay for detection of Haemophilus influenzae type b in cerebrospinal fluid. CSF, LAMP
1221  2011 Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. FDA, HIV, IQR
1222  2011 National and state vaccination coverage among children aged 19-35 months--United States, 2010. HepA, HepB, MMR, NIS, PCV
1223  2011 Neurodiagnostic evaluation of the child with a simple febrile seizure. AAP
1224  2011 One-year post-primary antibody persistence and booster immune response to a DTaP-IPV//PRP~T vaccine (Pentaxim) given at 18 - 19 months of age in South African children primed at 6, 10 and 14 weeks of age with the same vaccine. GMTs, SC, SP
1225  2011 Outer membrane protein complex of Meningococcus enhances the antipolysaccharide antibody response to pneumococcal polysaccharide-CRM₁₉₇ conjugate vaccine. Ab, IL-2, OMPC, PBS, PS, TLR2, TNF-alpha
1226  2011 Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial. ---
1227  2011 Rapid assessment of Hib disease burden in Vietnam. RAT
1228  2011 Reduced thymic size but no evidence of impaired thymic function in uninfected children born to human immunodeficiency virus-infected mothers. HIV-EU
1229  2011 Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity. DC, MoDC, OMP, PRP
1230  2011 Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine. CBA
1231  2011 Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age. AU, MCC, MMR, PRP, SBA
1232  2011 Ten years of Hib vaccination in Italy: prevalence of non-encapsulated Haemophilus influenzae among invasive isolates and the possible impact on antibiotic resistance. ---
1233  2011 The continuing role of Haemophilus influenzae type b carriage surveillance as a mechanism for early detection of invasive disease activity. ---
1234  2011 Up-to-date Haemophilus influenzae type b vaccination coverage during a vaccine shortage. IIS
1235  2011 [Haemophilus influenzae type b vaccine]. ---
1236  2011 [Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China]. ---
1237  2011 [Meningitis and encephalitis in Poland in 2009]. ---
1238  2012 A multiplex touchdown PCR for detection of Streptococcus pneumoniae, Haemophilus influenzae type b and Mycobacterium tuberculosis complex in sputum samples. cap, cpsA, MTBC, SP
1239  2012 Antibody response to Haemophilus influenzae type-b conjugate vaccine in children and young adults with congenital asplenia or after undergoing splenectomy. GMC
1240  2012 Clear and present danger: in childhood meningitis. The importance of Hib immunisation in infancy and high-risk groups. ---
1241  2012 Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). CENTRAL, CI, DTP, H. influenzae, HBV, IPV, ITT, OPV, RCTs, RR, WHO
1242  2012 Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries. NRA, QC, WHO
1243  2012 Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials. ---
1244  2012 DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™): a guide to its use in infants. ---
1245  2012 Effects of a nationwide Hib vaccine shortage on vaccination coverage in the United States. NIS
1246  2012 Epiglottitis and related complications in adults. Case reports and review of the literature. ---
1247  2012 Evaluation of haemophilus influenzae type b vaccine for routine immunization in Nepali infants. HibCV, PRP
1248  2012 Expanding poliomyelitis and measles surveillance networks to establish surveillance for acute meningitis and encephalitis syndromes--Bangladesh, China, and India, 2006-2008. AES, AFP, AMES, GFIMS, JE, VPDs, WHO
1249  2012 Genotyping of Haemophilus influenzae type b in pre-vaccination era. ---
1250  2012 Haemophilus influenzae serotype B (Hib) seroprevalence in England and Wales in 2009. PRP
1251  2012 Haemophilus influenzae type b combination vaccines and atopic disorders: a prospective cohort study. AD, DPT-Hib-IPV, ORs
1252  2012 Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009. ---
1253  2012 Haemophilus influenzae type b disease in Auckland children during the Hib vaccination era: 1995-2009. ---
1254  2012 Haemophilus influenzae type b infection, vaccination, and H. influenzae carriage in children in Minnesota, 2008-2009. DTaP
1255  2012 Haemophilus influenzae Type b Meningitis in the Short Period after Vaccination: A Reminder of the Phenomenon of Apparent Vaccine Failure. ---
1256  2012 Immune response to Haemophilus influenzae type b conjugate vaccine in preterm infants. PRP
1257  2012 Immune response to Haemophilus influenzae type b vaccination in patients with chronic renal failure. ---
1258  2012 Immunization against Haemophilus Influenzae Type b in Iran; Cost-utility and Cost-benefit Analyses. ---
1259  2012 Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan. H. influenzae, OPA, SAEs
1260  2012 Immunogenicity and safety of LBVH0101, a new Haemophilus influenzae type b tetanus toxoid conjugate vaccine, compared with Hiberix™ in Korean infants and children: a randomized trial. GMC, WHO
1261  2012 Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries. ---
1262  2012 Improvement in the purification process of the capsular polysaccharide from Haemophilus influenzae type b by using tangential ultrafiltration and diafiltration. RP
1263  2012 Introduction of Haemophilus influenzae type b (Hib) as pentavalent(DPT-HepB-Hib) vaccine in two states of India. ---
1264  2012 Invasive disease due to Haemophilus influenzae serotype b ten years after routine vaccination, South Africa, 2003-2009. HibCV
1265  2012 Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes. ABCs, Hi
1266  2012 Lessons learned from the 2007 to 2009 Haemophilus influenzae type B vaccine shortage: implications for future vaccine shortages and public health preparedness. CDC, IIS, IPMs
1267  2012 Low immune response to hepatitis B vaccine among children in Dakar, Senegal. EPI
1268  2012 Measurement of antibodies to pneumococcal, meningococcal and haemophilus polysaccharides, and tetanus and diphtheria toxoids using a 19-plexed assay. ELISA
1269  2012 Meningitis in children in Fiji: etiology, epidemiology, and neurological sequelae. CSF, CWMH, PsaA
1270  2012 Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs. ---
1271  2012 Natural immunity to hemophilus influenza type b in children, south of Iran: need for vaccination. ---
1272  2012 Naturally acquired and conjugate vaccine-induced antibody to Haemophilus influenzae type b (Hib) polysaccharide in Malian children: serological assessment of the Hib immunization program in Mali. ---
1273  2012 Optimising automation of a manual enzyme-linked immunosorbent assay. ELISAs
1274  2012 Pentavalent vaccine: a major breakthrough in India's Universal Immunization Program. ---
1275  2012 Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity. MAPK
1276  2012 Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study. DTaP-IPV, GMCs
1277  2012 Quantitative proton magnetic resonance determination of N,N-dimethylformamide in one intermediate of the Quimi-Hib vaccine. DMF
1278  2012 Recurrent bacterial meningitis by three different pathogens in an isolated asplenic child. ICA, PRP
1279  2012 Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era. COPD
1280  2012 Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations. Tdap
1281  2012 The burden of nonencapsulated Haemophilus influenzae in children and potential for prevention. ncHi
1282  2012 Treatment of bacterial meningitis: an update. BBB, CSF, N. menigitidis, S. pneumoniae
1283  2012 Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom. ---
1284  2012 Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco. ---
1285  2012 [Colonization and transmission of Haemophilus influenzae type b (Hib)]. ---
1286  2013 A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine. ---
1287  2013 A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age. heptavalent vaccine, MenC
1288  2013 A randomized, controlled, blinded study of the safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine injected at different intramuscular sites in Chinese infants. ---
1289  2013 Acute epiglottitis in the era of post-Haemophilus influenzae type B (HIB) vaccine. ---
1290  2013 Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. DTaP, IPV
1291  2013 Antibiotic non-susceptibility among Streptococcus pneumoniae and Haemophilus influenzae isolates identified in African cohorts: a meta-analysis of three decades of published studies. SXT
1292  2013 Antibody persistence of two pentavalent DTwP-HB-Hib vaccines to the age of 15-18 months, and response to the booster dose of quadrivalent DTwP-Hib vaccine. DTwP
1293  2013 Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. EPI, HepB, HEU, HUU
1294  2013 Assessment of immunogenicity and safety following primary and booster immunisation with a CRM197 -conjugated Haemophilus influenzae type B vaccine in healthy Chinese infants. ELISA, PRP
1295  2013 Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea. NIP, PCV
1296  2013 Comparing Haemophilus influenzae type b conjugate vaccine schedules: a systematic review and meta-analysis of vaccine trials. ---
1297  2013 Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India. DALYs
1298  2013 Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants. ---
1299  2013 Detection of Streptococcus pneumoniae and Haemophilus influenzae type B by real-time PCR from dried blood spot samples among children with pneumonia: a useful approach for developing countries. DBS
1300  2013 Effectiveness of Haemophilus influenzae type b conjugate vaccine on radiologically-confirmed pneumonia in young children in Pakistan. VE
1301  2013 Effectiveness of Haemophilus influenzae type b vaccines administered according to various schedules: systematic review and meta-analysis of observational data. VE
1302  2013 Emergence of non-serotype b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in northwestern Ontario. Hia
1303  2013 Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. GAPPD, IQR, LMIC, RSV, SP, WHO
1304  2013 Estimating meningitis hospitalization rates for sentinel hospitals conducting invasive bacterial vaccine-preventable diseases surveillance. CSF, IB-VPD, WHO
1305  2013 Evaluation of the effectiveness of Haemophilus influenzae type b conjugate vaccine introduction against radiologically-confirmed hospitalized pneumonia in young children in Ukraine. ---
1306  2013 Follow-up of cases of Haemophilus influenzae type b meningitis to determine its long-term sequelae. ---
1307  2013 Global Immunization Vision and Strategy (GIVS): a mid-term analysis of progress in 50 countries. cMYPs, GAVI, GIVS, HepB, WHO
1308  2013 Glycoconjugate vaccines. ---
1309  2013 Haemophilus influenza type b disease and vaccination in India: knowledge, attitude and practices of paediatricians. ---
1310  2013 Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011. Hia
1311  2013 Haemophilus influenzae type b (Hib) Vaccination Position Paper – July 2013. ---
1312  2013 Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations. SAGE, WHO
1313  2013 Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction. ---
1314  2013 HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide. HPAEC-PAD
1315  2013 Identification of Haemophilus influenzae clones associated with invasive disease a decade after introduction of H. influenzae serotype b vaccination in Italy. MLST, ncHi, STs
1316  2013 Immunization in practice - clearing the cobwebs. BCG, DPT, OPV
1317  2013 Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India. ---
1318  2013 Impact of Haemophilus influenzae Type b conjugate vaccine in Mongolia: prospective population-based surveillance, 2002-2010. ---
1319  2013 Impact of Haemophilus influenzae type b vaccination on the incidence of invasive Haemophilus influenzae disease in France, 15 years after its introduction. Hi
1320  2013 Impact of introduction of the Haemophilus influenzae type b conjugate vaccine into childhood immunization on meningitis in Bangladeshi infants. ---
1321  2013 Incidence of Haemophilus influenzae type b disease in The Gambia 14 years after introduction of routine Haemophilus influenzae type b conjugate vaccine immunization. ---
1322  2013 Incidence of radiologically-confirmed pneumonia and Haemophilus influenzae type b carriage before Haemophilus influenzae type b conjugate vaccine introduction in Central Vietnam. RCP
1323  2013 Infant meningococcal vaccination: Advisory Committee on Immunization Practices (ACIP) recommendations and rationale. ACIP
1324  2013 Intraperitoneal inoculation of Haemophilus influenzae local isolates in BALB/c mice model in the presence and absence of virulence enhancement agents. Hi, VEA
1325  2013 Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination? PHE
1326  2013 Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011. ---
1327  2013 Maternal Supplementation with LGG Reduces Vaccine-Specific Immune Responses in Infants at High-Risk of Developing Allergic Disease. LGG
1328  2013 Microbiological characterization of Streptococcus pneumoniae and non-typeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines. BLNAR, BLPACR, BLPAR, ERSP, MEF
1329  2013 Mortality and neurodevelopmental outcomes of acute bacterial meningitis in children aged <5 years in Pakistan. ABM
1330  2013 National Immunization Program in Iran: whys and why nots. aP, OPV, wP
1331  2013 Pentavalent DTP vaccine: need to be incorporated in the vaccination program of India. HepB, NTAGI, UIP, WHO
1332  2013 Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). ACIP
1333  2013 Prospective multi-centre sentinel surveillance for Haemophilus influenzae type b & other bacterial meningitis in Indian children. CMC, CSF, HibCV
1334  2013 Prospective safety monitoring of Haemophilus influenzae type b and heptavalent pneumococcal conjugate vaccines in Kagoshima, Japan. ---
1335  2013 Randomized, controlled, multicenter study of the immunogenicity and safety of a fully liquid combination diphtheria-tetanus toxoid-five-component acellular pertussis (DTaP5), inactivated poliovirus (IPV), and haemophilus influenzae type b (Hib) vaccine compared with a DTaP3-IPV/Hib vaccine administered at 3, 5, and 12 months of age. GMC, IPV, PRP
1336  2013 Recent mechanistic insights on glycoconjugate vaccines and future perspectives. ---
1337  2013 Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria. MenC
1338  2013 Revised recommendations for the prevention of secondary Haemophilus influenzae type b (Hib) disease. ---
1339  2013 Serotypes, antimicrobial susceptibility, and beta-lactam resistance mechanisms of clinical Haemophilus influenzae isolates from Bulgaria in a pre-vaccination period. BLPACR, BLPAR, RTIs
1340  2013 Should corticosteroids be used in bacterial meningitis in children? ---
1341  2013 Specific antibodies against vaccine-preventable infections: a mother-infant cohort study. ---
1342  2013 The burden of epiglottitis among Japanese children before the Haemophilus influenzae type b vaccination era: an analysis using a nationwide administrative database. ---
1343  2013 The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review. LiST, PCV, RCTs
1344  2013 The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. ITP
1345  2013 The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction. ---
1346  2013 The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. ---
1347  2013 The history of pneumococcal conjugate vaccine development: dose selection. PCVs, PS
1348  2013 Three-year antibody persistence and safety after a single dose of combined haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in Hib-primed toddlers. MenC
1349  2013 TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination. DALY, ICERs, PCV, RV, RVGE
1350  2013 [Analysis of pathogen spectrum of Encephalitis/Meningitis in northwestern area of China]. HSV, JEV, Nm
1351  2013 [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis]. BLNAR, CSF, CTRX, MIC, TAZ/PIPC
1352  2014 A fine-tuned interaction between trimeric autotransporter haemophilus surface fibrils and vitronectin leads to serum resistance and adherence to respiratory epithelial cells. Hsf, MAC, NHS
1353  2014 A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of age. MenC
1354  2014 Antibodies against Haemophilus influenzae type b in The Gambia: investigating the extent of protection across age groups. ---
1355  2014 Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and Haemophilus influenzae type b vaccination, 2000-2012. ART, CSF, IRR, NTS
1356  2014 Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay. CAP
1357  2014 Changes in immunization program managers' perceptions of programs' functional capabilities during and after vaccine shortages and pH1N1. IIS, IPMs, pH1N1
1358  2014 Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan. ---
1359  2014 Childhood very severe pneumonia and meningitis-related hospitalization and death in Yemen, before and after introduction of H. influenzae type b (Hib) vaccine. ---
1360  2014 Development and validation of high-performance size exclusion chromatography methods to determine molecular size parameters of Haemophilus influenzae type b polysaccharides and conjugates. CGPC, HPSEC, PRP, RI
1361  2014 Estimation of the herd protection of Haemophilus influenzae type b conjugate vaccine against radiologically confirmed pneumonia in children under 2 years old in Dhaka, Bangladesh. ---
1362  2014 Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection. ELISA, PRP, SBA
1363  2014 Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines--exploratory analyses within a randomised controlled trial. ELISPOT, MenC
1364  2014 Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine. MenC, PRP, SBA
1365  2014 Fully liquid DTaP-IPV-Hib pediatric combination vaccine (Pediacel): a review of 18 years of clinical experience. IPV
1366  2014 Hexavalent vaccines for immunization in paediatric age. DTaP
1367  2014 High cost is the primary barrier reported by physicians who prescribe vaccines not included in India's Universal Immunization Program. PCV, RV, UIP
1368  2014 Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study. DTP, HepB, wP
1369  2014 Leaning in to the power of the possible: the crucial role of women scientists on preventing Haemophilus influenzae type b disease. ---
1370  2014 Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to emerging vaccine manufacturers. NIP
1371  2014 Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster. IgG, MenC, PRP
1372  2014 Low incidence of children with acute epiglottis after introduction of vaccination. ---
1373  2014 Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study. CSF, N. meningitidis, PCR, S. pneumoniae
1374  2014 Natural immunity against Haemophilus influenza type B in splenectomised Beta-thalassaemia children. ---
1375  2014 Near disappearance of childhood invasive Haemophilus influenzae type b disease in Singapore. ---
1376  2014 Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transfer. NVI
1377  2014 Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). ACIP
1378  2014 Prioritization of the introduction of new vaccines to the national immunization program in the Republic of Korea. HepA, HPV, NIP, RV, VPDs
1379  2014 Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines. DPT, DPT, PBMCs, PGE2
1380  2014 Recent trends in pediatric bacterial meningitis in Japan--a country where Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines have just been introduced. ---
1381  2014 Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate. PRP, Rbt-5-P
1382  2014 Routine childhood vaccination programme coverage, El Salvador, 2011-In search of timeliness. BCG, DTP, MMR
1383  2014 Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries. DPT
1384  2014 The first reported case of possible Haemophilus influenzae type b vaccine failure from Kuwait and literature-review. ---
1385  2014 The impact of residency and urbanicity on Haemophilus influenzae Type b and pneumococcal immunization in Shanghai Children: a Retrospective Cohort Study. PCV
1386  2014 The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines. CI, IHiD, IPD, IRR
1387  2014 The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. ---
1388  2014 The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal. ---
1389  2014 Use of immuno assays during the development of a Hemophilus influenzae type b vaccine for technology transfer to emerging vaccine manufacturers. ELISA
1390  2015 A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States. OR, PDD, VSD
1391  2015 A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine. ---
1392  2015 Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013. AEs, VAERS
1393  2015 Association of beta-Lactam-Sensitive Haemophilus influenzae Type B with Adenoid Biofilm Formation in Patients with Adenoidectomy Surgery. MEE-AH, OSA
1394  2015 Carbohydrate-Based Vaccines: An Overview. CPS
1395  2015 Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam. DALY
1396  2015 Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different polysaccharide chain lengths. PRP
1397  2015 Estimated costs attributable to events of "out-of-temperature" in the stockpiling of hexavalent vaccines occurring in Italy. DTP, HBV, NHS
1398  2015 Evaluation of Haemophilus influenzae type b carrier status among children 10 years after the introduction of Hib vaccine in Brazil. NP
1399  2015 Evolving trends of neonatal and childhood bacterial meningitis in northern Taiwan. ---
1400  2015 Genotyping of Haemophilus influenzae type b strains and their incidence in the clinical samples isolated from Iranian patients. ---
1401  2015 Haemophilus influenzae Type f Hijacks Vitronectin Using Protein H To Resist Host Innate Immunity and Adhere to Pulmonary Epithelial Cells. Hif, PH, VN
1402  2015 Hearing impairment after childhood bacterial meningitis dependent on etiology in Luanda, Angola. BM
1403  2015 HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples. CPS, HPAEC-PAD, HPSEC, IPC, PRP
1404  2015 Identification of antigen-specific B cell receptor sequences using public repertoire analysis. TT
1405  2015 Identification of Haemophilus influenzae Type b Isolates by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. MALDI-TOF MS
1406  2015 Immunization status of internationally adopted children in Rome, Italy. ---
1407  2015 Immunogenicity and safety of 3-dose primary vaccination with combined DTPa-HBV-IPV/Hib vaccine in Canadian Aboriginal and non-Aboriginal infants. GMCs, HBV
1408  2015 IMMUNOGENICITY AND SAFETY OF QUINVAXEM (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE. DPT, HepB
1409  2015 Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial. MenC, TT
1410  2015 Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes. CI, RR, RT-PCR
1411  2015 Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data. ---
1412  2015 Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013. BHDSS, CI
1413  2015 Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule. DT, GMTs, GPs, MenC, PT, SBA, TT
1414  2015 Knowledge gaps on paediatric respiratory infections in Morocco, Northern Africa. ARI
1415  2015 Long-term trends in invasive Haemophilus influenzae type B disease among indigenous Australian children following use of PRP-OMP and PRP-T vaccines. CI
1416  2015 Lower response to early T-cell-dependent vaccination after neurotrauma or neurosurgery in adults. ---
1417  2015 Maternally acquired IgG immunity in neonates born to renal transplanted women. ---
1418  2015 National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19-35 Months - United States, 2014. DTaP, HepA, HepB, HepB, MMR, NIS, PCV
1419  2015 Nationwide survey of the development of drug resistance in the pediatric field in 2007, 2010, and 2012: drug sensitivity of Haemophilus influenzae serotype b strain in Japan. ---
1420  2015 Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada. Hia
1421  2015 Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France. ITP, Nm, SP
1422  2015 Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components. MenC
1423  2015 Pediatric orbital cellulitis in the Haemophilus influenzae vaccine era. ---
1424  2015 Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia. CFRs, DALYs, GDP, PCV10, SIAs, WHO
1425  2015 Polysaccharide purification from Haemophilus influenzae type b through tangential microfiltration. TMF
1426  2015 SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN. AEs, PMS
1427  2015 Streptococcus pneumoniae and Haemophilus influenzae in paediatric meningitis patients at Goroka General Hospital, Papua New Guinea: serotype distribution and antimicrobial susceptibility in the pre-vaccine era. CSF, EPI, PCVs, PNG
1428  2015 Study of the chemical stability of the capsular polysaccharide produced by Haemophilus influenzae type b. ---
1429  2015 The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule. SAEs
1430  2015 Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013. MD
1431  2015 Trends in the epidemiology of invasive Haemophilus influenzae disease in Queensland, Australia from 2000 to 2013: what is the impact of an increase in invasive non-typable H. influenzae (NTHi)? NTHi
1432  2015 Two or three primary dose regime for Haemophilus influenzae type b conjugate vaccine: meta-analysis of randomized controlled trials. CI
1433  2015 Update on Routine Childhood and Adolescent Immunizations. DTaP, Tdap
1434  2015 Vaccine preventable meningitis in Malaysia: epidemiology and management. ---
1435  2015 [Comparing the safety of vaccination on vastus lateralis muscle and deltoid muscle of infants with haemophilus influenzae type b conjugate vaccine]. SAE
1436  2015 [Evaluation of safety of haemophilus influenza type b(Hib) conjugate vaccine in postmarketing based on the immunization information management system]. AEFI, HibCV
1437  2015 [Haemophilus influenzae type b in Italy--after thirty years of vaccination may we lower our guard?]. ---
1438  2015 [Haemophilus influenzae type b meningitis in a vaccinated, immunocompetent infant with reactive arthritis]. ---
1439  2015 [Nasopharyngeal Hib Carriage Among Healthy Children Attending Daycare Centers in Yokohama After One Year of a Publicly Funded Vaccine Program]. ---
1440  2016 A 15-year retrospective analysis of prognostic factors in childhood bacterial meningitis. CI, CSF, ICU, OR
1441  2016 A glycoconjugate of Haemophilus influenzae Type b capsular polysaccharide with tetanus toxoid protein: hydrodynamic properties mainly influenced by the carbohydrate. TT
1442  2016 A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b. CV, SBA, TTC
1443  2016 Adult-onset Invasive Haemophilus influenzae Type f Caused by Acute Lower Leg Cellulitis. Hif
1444  2016 Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines. CRM197, DTPa, MenC, PRP, rSBA, SBA
1445  2016 Applying Central Composite Design and Response Surface Methodology to Optimize Growth and Biomass Production of Haemophilus influenzae Type b. CCD, PRP, RSM
1446  2016 Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci. SBA
1447  2016 Clinical and Molecular Epidemiology of Childhood Invasive Nontypeable Haemophilus influenzae Disease in England and Wales. MLST, NTHi, PHE
1448  2016 Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants. BCG, HEU
1449  2016 Development and Optimization of a Homemade ELISA Kit for Detection of Antibodies Against Haemophilus influenzae Type b. ELISA, PRP
1450  2016 DNA aptamers for the detection of Haemophilus influenzae type b by cell SELEX. ABM, CSF, SELEX
1451  2016 Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study. KCH, KHDSS
1452  2016 Evaluation of Pastorex meningitis kit performance for the rapid identification of Neisseria meningitidis serogroup C in Nigeria. CSF, LR, NmC, NmC, RDTs
1453  2016 Food and Drug Administration Approval for Use of Hiberix as a 3-Dose Primary Haemophilus influenzae Type b (Hib) Vaccination Series. FDA, PRP
1454  2016 Global Routine Vaccination Coverage, 2015. PCV, UNICEF, WHO
1455  2016 Hib Vaccines: Past, Present, and Future Perspectives. ---
1456  2016 How a New Health Intervention Affects the Health Systems? Learnings from Pentavalent Vaccine Introduction in India. AEFI, PIE
1457  2016 Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia. ---
1458  2016 Immunogenicity and protective immunity against otitis media caused by pneumococcus in mice of Hib conjugate vaccine with PsaA protein carrier. PsaA, TT
1459  2016 Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study. DTaP, PRP, PRP-T
1460  2016 Immunogenicity and safety of two doses of catch-up immunization with Haemophilus influenzae type b conjugate vaccine in Indian children living with HIV. ART, HibCV, NP
1461  2016 Impact of Haemophilus influenzae Type B Conjugate Vaccines on Nasopharyngeal Carriage in HIV-infected Children and Their Parents From West Bengal, India. HibCV, HIV
1462  2016 Invasive bacterial infections in Gambians with sickle cell anemia in an era of widespread pneumococcal and hemophilus influenzae type b vaccination. SCA
1463  2016 Laboratory characterization of invasive Haemophilus influenzae isolates from Nunavut, Canada, 2000-2012. Hi, NT, ST
1464  2016 Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluation. EE
1465  2016 Process development of a New Haemophilus influenzae type b conjugate vaccine and the use of mathematical modeling to identify process optimization possibilities. QC
1466  2016 Response to immunization in children born to renal transplant recipients using immunosuppressive drugs during gestation. ---
1467  2016 Safety and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTPa-IPV/Hib) vaccine in healthy Vietnamese toddlers: An open-label, phase III study. DTPa-IPV
1468  2016 Self-reported prenatal influenza vaccination and early childhood vaccine series completion. CI
1469  2016 Status of New Vaccine Introduction - Worldwide, September 2016. EPI, Gavi, GVAP, HPV, PCV, WHO
1470  2016 Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12-18 months in Shanghai, China: a cross-sectional study. PCV
1471  2016 The Effect of Maternal Peripartum Anti-TNFalpha Use on Infant Immune Response. ADA, IFX
1472  2016 The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials. CRM, MenC, TT
1473  2016 Timing of Haemophilus influenzae type b vaccination after cardiac surgery. CHD, CPB
1474  2016 Vaccinations in asplenic adults. ---
1475  2017 A review of Haemophilus influenzae disease in Europe from 2000-2014: challenges, successes and the contribution of hexavalent combination vaccines. ---
1476  2017 Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines. ---
1477  2017 Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran. NIP
1478  2017 Collaborative study on saccharide quantification of the Haemophilus influenzae type b component in liquid vaccine presentations. BSP, EDQM, HPAEC-PAD, WHO
1479  2017 Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants. MenC
1480  2017 DTaP5-HB-IPV-Hib Vaccine (Vaxelis): A Review of its Use in Primary and Booster Vaccination. ---
1481  2017 Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand. ICERs, QALY, THB
1482  2017 Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review. WHO
1483  2017 Effect of stepwise perinatal immunization education: A cluster-randomized controlled trial. ---
1484  2017 Evaluation of the line probe assay for the rapid detection of bacterial meningitis pathogens in cerebrospinal fluid samples from children. CSF, LPA, PCR
1485  2017 Experimental design and metabolic flux analysis tools to optimize industrially relevant Haemophilus influenzae type b growth medium. ---
1486  2017 Factors That Negatively Affect the Prognosis of Pediatric Community-Acquired Pneumonia in District Hospital in Tanzania. CAP, DBS, PCR, S. p, SA
1487  2017 Functional antibodies to Haemophilus influenzae type B, Neisseria meningitidis, and Streptococcus pneumoniae contained in intravenous immunoglobulin products. IVIG, PAD
1488  2017 Haemophilus influenzae Type a Meningitis in Immunocompetent Child, Oman, 2015. ---
1489  2017 Haemophilus influenzae type b carriage and burden of its related diseases in Chinese children: Systematic review and meta-analysis. ALRI, CNKI
1490  2017 Haemophilus influenzae type b meningitis in a vaccinated and immunocompetent child. CSF
1491  2017 Haemophilus influenzae type B meningitis: Is there a re-emergence? 24 years of experience in a children's hospital. ---
1492  2017 Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid. CHO, FHA, GMC, MBL, mHib, TT
1493  2017 High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination. GNI, PCV
1494  2017 Immunization status in childhood cancer survivors: A hidden risk which could be prevented. ---
1495  2017 Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib). MCC
1496  2017 Invasive Haemophilus influenzae Infection in Patients With Cancer. NTHi
1497  2017 Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants. AEs, SAEs
1498  2017 Measuring the timeliness of childhood vaccinations: Using cohort data and routine health records to evaluate quality of immunisation services. DTP, Men C, MMR
1499  2017 Modeling the Potential for Vaccination to Diminish the Burden of Invasive Non-typhoidal Salmonella Disease in Young Children in Mali, West Africa. iNTS, NTS
1500  2017 Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b. ---
1501  2017 Multiplexed instrument-free meningitis diagnosis on a polymer/paper hybrid microfluidic biochip. aCSF, LAMP, N. meningitidis, POC, S. pneumoniae
1502  2017 Pediatric bacterial meningitis in Japan, 2013-2015 - 3-5 years after the wide use of Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines. PCV
1503  2017 Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan. DPT, MSF
1504  2017 Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia. ALL, VPDs
1505  2017 Single variant bottleneck in the early dynamics of H. influenzae bacteremia in neonatal rats questions the theory of independent action. ---
1506  2017 The Asplenic Patient: Post-Insult Immunocompetence, Infection, and Vaccination. ---
1507  2017 The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action. AIP, CDC, Hia, NRC, PHAC
1508  2017 The evidence for non-typeable Haemophilus influenzae as a causative agent of childhood pneumonia. NTHi
1509  2017 The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: Secondary analysis of a randomised controlled trial. ---
1510  2017 Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016. DTaP, HepB, MMR, NIS-Child, PCV, VFC
1511  2017 Vaccines to prevent pneumonia in children - a developing country perspective. GVAP
1512  2017 [Acute epiglottitis due to Haemophilus influenzae b: A severe consequence of increased skepticism about vaccination]. ---
1513  2018 A modular synthetic route to size-defined immunogenic Haemophilus influenzae b antigens is key to the identification of an octasaccharide lead vaccine candidate. PRP
1514  2018 A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan. CI, IRR
1515  2018 A post-conflict vaccination campaign, Central African Republic. DTP, PCV
1516  2018 A Registry for Patients With Asplenia/Hyposplenism Reduces the Risk of Infections With Encapsulated Organisms. IMD, IPD, OPSI
1517  2018 Acute epiglottitis caused by community-acquired methicillin-resistant Staphylococcus aureus in a healthy infant. MRSA
1518  2018 Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center. HSCT
1519  2018 Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies. GMC, PRP
1520  2018 Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15. PCV, UR
1521  2018 Clinical and Bacteriologic Analysis of Nontypeable Haemophilus influenzae Strains Isolated from Children with Invasive Diseases in Japan from 2008 to 2015. NTHi
1522  2018 Comparison of serum bactericidal and antibody titers induced by two Haemophilus influenzae type b conjugate vaccines: A phase III randomized double-blind study. SBA
1523  2018 Conjugate Haemophilus influenzae type b vaccines for sickle cell disease. RCTs, SCD
1524  2018 Cord Blood Antiparasite Interleukin 10 as a Risk Marker for Compromised Vaccine Immunogenicity in Early Childhood. DT, HBV, IgG, PC
1525  2018 Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China. ICER, UNICEF
1526  2018 Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009-2015. ---
1527  2018 Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study. ---
1528  2018 Epidemiology of bacterial meningitis in children admitted to Gondar University Hospital in the post pneumococcal vaccine era. CABM, CSF, GUH
1529  2018 Expanded program of immunization in the Maghreb. Case study of Tunisia.Systematic review of the literature. EPI
1530  2018 Extension of French vaccination mandates: from the recommendation of the Steering Committee of the Citizen Consultation on Vaccination to the law. ---
1531  2018 Global Routine Vaccination Coverage - 2017. GVAP, HepB, UNICEF, WHO
1532  2018 Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales. anti-PRP
1533  2018 IgE anti-Haemophilus influenzae type b (Hib) antibodies detected in serum of Hib-vaccinated asthmatic and non-asthmatic pediatric patients. IgE, OD
1534  2018 Immune responses to vaccine-preventable diseases among toddlers and preschool children after primary immunization and first booster in Northwestern Algiers, Algeria. GMAI
1535  2018 Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial. aP, DTaP, HBV, PT, Tdap
1536  2018 In Search of Factors Negatively Affecting Vaccine Immunity to Pertussis in Preschool Children Before the Administration of the First Booster. ELISA, GLZ
1537  2018 Incidence and aetiology of bacterial meningitis among children aged 1-59 months in South Asia: systematic review and meta-analysis. CI
1538  2018 Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012-2016. NTHi, PBP3, STs
1539  2018 Infectious Disease Risk and Vaccination in Northern Syria after 5 Years of Civil War: The MSF Experience. KHA, MSF, SIA, VPD
1540  2018 Integrated Safety Profile of a New Approved, Fully-liquid DTaP5-HB-IPV-Hib Vaccine. AEs
1541  2018 Long-term regulation of local cytokine production following immunization in mice. DTaP, G-CSF, HPV, NET
1542  2018 Nontypable Haemophilus influenzae Septicemia and Urinary Tract Infection Associated with Renal Stone Disease. ---
1543  2018 Persistence of Vaccine-Induced Immunity in Preschool Children: Effect of Gestational Age. MMR
1544  2018 Public subsidies and the recommendation of child vaccines among primary care physicians: a nationwide cross-sectional study in Japan. HPV, PCV
1545  2018 RNA gene profile variation in peripheral blood mononuclear cells from rhesus macaques immunized with Hib conjugate vaccine, Hib capsular polysaccharide and TT carrier protein. CPS, TT
1546  2018 Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands. CMV, IgG, MenC, NHI, SES
1547  2018 Sudden death from acute epiglottitis in a toddler. ---
1548  2018 The Incidence of Pediatric Invasive Bacterial Diseases in Nippon Medical School Chiba Hokusoh Hospital before and after the Introduction of Conjugate Vaccines. IPD
1549  2018 The risk of neurodevelopmental disorders following Thimerosal-containing Hib vaccine in comparison to Thimerosal-free Hib vaccine administered from 1995 to 1999 in the United States. NDs, OR
1550  2018 The role of vaccines in fighting antimicrobial resistance (AMR). AMR, WHO
1551  2018 Utilizing pharmacy intervention in asplenic patients to improve vaccination rates. ---
1552  2018 Vaccination Coverage Among Children Aged 2 Years - U.S. Affiliated Pacific Islands, April-October, 2016. CNMI, DTaP, FSM, HepB, IPV, MMR, PCV, RMI, USAPI, VPDs
1553  2018 Vaccination Practices in Pediatric Dialysis Patients Across Europe. A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group Study. CKD, HAV, HBV, MMR, VZV
1554  2018 Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children. ---
1555  2019 Accuracy and quality of immunization data in Iran: findings from data quality self-assessment survey in 2017. DQS, EPI, PPS, QI
1556  2019 Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. II. Antibodies subclasses. PRP
1557  2019 Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy-a prospective, observational cohort study from the United Kingdom. DTx, FHA, Ig, PRN, PTX, TTx
1558  2019 Causes of Pediatric Meningitis in Botswana: Results From a 16-Year National Meningitis Audit. CSF
1559  2019 Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. CrI, NP-OP, RSV
1560  2019 Characterization of Vaccination Policies for Attendance and Employment at Day/Summer Camps in New York State. DTaP, MMR, Tdap
1561  2019 Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b. CPS, PRP
1562  2019 Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands. GMC/T, MenC
1563  2019 Comparison of Haemophilus influenzae Seroprevalence in Serum Samples Collected from 0-5-year-old Children in Japan in 1980, 1995, 2010, and 2012. PRP
1564  2019 Conjugate vaccines dramatically reshaped the epidemiology of bacterial meningitis in a well-defined child population. IR
1565  2019 Continuing surveillance of invasive Haemophilus influenzae disease in northwestern Ontario emphasizes the importance of serotype a and non-typeable strains as causes of serious disease: a Canadian Immunization Research Network (CIRN) Study. CIRN, Hia, ST
1566  2019 DTaP-IPV-HepB-Hib Vaccine (Hexyon): An Updated Review of its Use in Primary and Booster Vaccination. HB
1567  2019 Effect of nontypeable Haemophilus influenzae protein E (PE) as a microbial adjuvant on the amount of antibody against PRP of Haemophilus influenzae type b (Hib) in BALB/c mice. PE
1568  2019 Effectiveness of Haemophilus influenzae type b vaccination after splenectomy - impact on selected immunological parameters. NK, NKT, Treg
1569  2019 Factors associated with uptake of Haemophilus influenzae type b vaccination in Shanghai, China. ---
1570  2019 Haemophilus influenzae type b vaccination and anthropometric, cognitive, and schooling outcomes among Indian children. pp
1571  2019 Haemophilus influenzae Type f Meningitis Complicated by Bilateral Subdural Empyema, Central Venous Thrombosis, and Bilateral Sensorineural Hearing Loss in an Immunocompetent 12-month-old. ---
1572  2019 Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers. TT
1573  2019 Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease. SCD
1574  2019 Integration of hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B virus, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine within existing national recommendations following a birth dose of monovalent hepatitis B virus vaccine: results of a systematic review in the Asia Pacific region. HBV
1575  2019 National, regional, and state-level burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in India: modelled estimates for 2000-15. NPNM, UR, WHO/MCEE
1576  2019 New vaccine introductions in Africa before and during the decade of vaccines - Are we making progress? PCV, RCV
1577  2019 Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction. CSF, NmC
1578  2019 Sustained reductions of invasive infectious disease following general infant Haemophilus influenzae type b and pneumococcal vaccination in a Swedish Arctic region. ---
1579  2019 The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses. DTPa, FHA, GMC, PRN, PT, TIV
1580  2019 The influence of neonatal Bacille Calmette-Guerin (BCG) immunisation on heterologous vaccine responses in infants. BCG, GMC
1581  2019 Today's vaccination policies in Italy: The National Plan for Vaccine Prevention 2017-2019 and the Law 119/2017 on the mandatory vaccinations. MMR
1582  2019 Vaccination herd effect experience in Latin America: a systematic literature review. LATAM, PCV, VHL
1583  2019 [Acute meningitis and encephalitis syndrome surveillance disease burden in four China prefectures]. AMES, Nm, SP
1584  2019 [Epiglottitis due to Haemophilus influenzae type b in the vaccination era: pediatric clinical case]. ---